Uncomplicated cases of measles typically improve within days of rash onset and resolve within 7–10 days.
People who have been vaccinated against measles but have incomplete protective immunity may experience a form of modified measles. Modified measles is characterized by a prolonged incubation period, milder, and less characteristic symptoms (sparse and discrete rash of short duration). Because development of the rash and conjunctivitis requires a functional immune system, immunocompromised people may not be diagnosed as readily.
Complications of measles are relatively common. Some are caused directly by the virus, while others are caused by viral suppression of the immune system. This phenomenon, known as "immune amnesia", increases the risk of secondary bacterial infections; two months after recovery there is an 11–73% decrease in the number of antibodies against other bacteria and viruses. Population studies from prior to the introduction of the measles vaccine suggest that immune amnesia typically lasts 2–3 years. Primate studies suggest that immune amnesia in measles is effected by replacement of memory lymphocytes with ones that are specific to measles virus, since they are destroyed after being infected by the virus. This creates lasting immunity to measles re-infection, but decreases immunity to other pathogens. Complications may be directly related to the virus - e.g. viral pneumonia or viral laryngotracheobronchitis (croup) - or related to the damage measles virus causes to tissues and the immune system. The most serious direct complications include acute encephalitis, corneal ulceration (leading to corneal scarring); and subacute sclerosing panencephalitis, a progressive and fatal inflammation of the brain that occurs in about 1 in 600 unvaccinated infants under 15 months. Common secondary infections include infectious diarrhea, bacterial pneumonia, and otitis media.
The death rate in the 1920s was around 30% for measles pneumonia. People who are at high risk for complications are infants and children aged less than 5 years; adults aged over 20 years; pregnant women; people with compromised immune systems, such as from leukemia, HIV infection or innate immunodeficiency; and those who are malnourished or have vitamin A deficiency. Complications are usually more severe in adults. Between 1987 and 2000, the case fatality rate across the United States was three deaths per 1,000 cases attributable to measles, or 0.3%. In underdeveloped nations with high rates of malnutrition and poor healthcare, fatality rates have been as high as 28%. In immunocompromised persons (e.g., people with AIDS) the fatality rate is approximately 30%.
Even in previously healthy children, measles can cause serious illness requiring hospitalization. One out of every 1,000 measles cases progresses to acute encephalitis, which often results in permanent brain damage. One to three out of every 1,000 children who become infected with measles will die from respiratory and neurological complications.
The virus is one of the most contagious human pathogens and is spread by coughing and sneezing via close personal contact or direct contact with secretions. It remains infectious for up to two hours via suspended respiratory droplets. It is not easily spread by fomites, because the virus is inactivated within a few hours by ultraviolet light and heat. It is also inactivated by trypsin, acidic environments, and ether. Measles is so contagious that if one person has it, 90% of non-immune people who have close contact with them (e.g., household members) will also become infected. Humans are the only natural hosts of the virus, and no other animal reservoirs are known to exist, although mountain gorillas are believed to be susceptible to the disease.
Risk factors for measles virus infection include immunodeficiency caused by HIV/AIDS, immunosuppression following receipt of an organ or a stem cell transplant, alkylating agents, or corticosteroid therapy, regardless of immunization status; travel to areas where measles commonly occurs or contact with travelers from such an area; and the loss of passive, inherited antibodies before the age of routine immunization.
The initial period of infection in the lung lasts for two to three days, and ends with the first period of viremia. Five to seven days after infection begins, the second viremia occurs, and the virus infects epithelial cells. The virus spreads along epithelial cells, initially in the respiratory tree via intercellular pores, and later in the linings of other organs and the respiratory tree via nectin-4 receptors. This causes the cough seen clinically, which aerosolizes the virus and enables it to spread.
Laboratory diagnosis of measles can be done with confirmation of positive measles IgM antibodies or detection of measles virus RNA from throat, nasal or urine specimen by using the reverse transcription polymerase chain reaction assay. This method is particularly useful to confirm cases when the IgM antibodies results are inconclusive. For people unable to have their blood drawn, saliva can be collected for salivary measles-specific IgA testing. Salivary tests used to diagnose measles involve collecting a saliva sample and testing for the presence of measles antibodies. This method is not ideal, as saliva contains many other fluids and proteins which may make it difficult to collect samples and detect measles antibodies. Saliva also contains 800 times fewer antibodies than blood samples do, which makes salivary testing additionally difficult. Positive contact with other people known to have measles adds evidence to the diagnosis.
Mothers who are immune to measles pass antibodies to their children while they are still in the womb, especially if the mother acquired immunity through infection rather than vaccination. Such antibodies will usually give newborn infants some immunity against measles, but these antibodies are gradually lost over the course of the first nine months of life. However, immunization with live vaccines is not recommended in pregnancy; pregnant people found to be non-immune to measles should be immunized after delivery. Infants under one year of age whose maternal anti-measles antibodies have disappeared become susceptible to infection with the measles virus.
It is generally recommended that children be immunized against measles at 12 months, as part of a three-part MMR vaccine (measles, mumps, and rubella). The vaccine is generally not given before this age because younger infants respond inadequately to the vaccine due to an immature immune system. A second dose of the vaccine is recommended between the ages of four and five, to increase rates of immunity. Adverse reactions to vaccination are rare, with fever and pain at the injection site being the most common. Life-threatening adverse reactions occur in less than one per million vaccinations (<0.0001%).
Administration of the MMR vaccine may prevent measles after exposure to the virus (post-exposure prophylaxis). Post-exposure prophylaxis guidelines are specific to jurisdiction and population. Passive immunization against measles by an intramuscular injection of antibodies could be effective up to the seventh day after exposure. Compared to no treatment, the risk of measles infection is reduced by 83%, and the risk of death by measles is reduced by 76%. However, the effectiveness of passive immunization in comparison to active measles vaccine is not clear.
The MMR vaccine is 95% effective for preventing measles after one dose if the vaccine is given to a child who is twelve months of age or older; if a second dose of the MMR vaccine is given, it will provide immunity in 97-99% of children.
"Vitamin A deficiency (VAD) is a major public health problem in low- and middle-income countries, affecting 190 million children under five years of age and leading to many adverse health consequences, including death." Vitamin A deficiency is rare in the United States. A meta-analysis of clinical trials conducted in countries where VAD is prevalent concluded that when children were supplemented with vitamin A, there was a 50% reduction in incidence of contracting measles. By way of comparison, vaccination with two doses of the measles vaccine in childhood provides 97-99% protection at preventing measles. Vitamin A supplementation is not thought to reduce the risk of death from measles. Children given high doses of vitamin A from supplements or cod liver oil can accumulate to toxic levels and this can lead to hypervitaminosis A and liver damage.
Some groups, such as young children and the severely malnourished, are also physician-administered vitamin A, which acts as an immunomodulator that boosts the antibody responses to measles and decreases the risk of serious complications. While vitamin A treatment does not cure the disease or reduce mortality in every age group, two doses (200,000 IU) of vitamin A was shown to reduce mortality in children younger than two years of age. In the 2025 U.S. outbreak, children are presenting at hospitals with measles and hypervitaminosis A because their parents were administering vitamin A sources (supplements or cod liver oil) as attempts of protection before the children became ill with measles.
Most people survive measles, though in some cases, complications may occur. About 1 in 4 individuals will be hospitalized and 1–2 in 1,000 will die. Complications are more likely in children under age 5, adults over age 20, and pregnant people. Pneumonia is the most common fatal complication of measles infection and accounts for 56–86% of measles-related deaths.
For people having had measles, it is rare to ever have a symptomatic reinfection.
Measles is extremely infectious and its continued circulation in a community depends on the generation of susceptible hosts by birth of children. In communities that generate insufficient new hosts the disease will die out. This concept was first recognized in measles by M.S. Bartlett in 1957, who referred to the minimum number supporting measles as the critical community size (CCS). Analysis of outbreaks in island communities suggested that the CCS for measles is around 250,000. Due to the ease with which measles is transmitted from person to person in a community, more than 95% of the community must be vaccinated in order to achieve herd immunity.
In 2011, the WHO estimated that 158,000 deaths were caused by measles. This is down from 630,000 deaths in 1990. As of 2018, measles remains a leading cause of vaccine-preventable deaths in the world. In developed countries the mortality rate is lower, for example in England and Wales from 2007 to 2017 death occurred between two and three cases out of 10,000. In children one to three cases out of every 1,000 die in the United States (0.1–0.2%). In populations with high levels of malnutrition and a lack of adequate healthcare, mortality can be as high as 10%. In cases with complications, the rate may rise to 20–30%.[medical citation needed] In 2012, the number of deaths due to measles was 78% lower than in 2000 due to increased rates of immunization among UN member states. Between 2000 and 2016, global cases decreased by 84%; by 2019 cases had increased to a total of 870,000, the highest since 1996.
Reported casesEven in countries where vaccination has been introduced, rates may remain high. Measles is a leading cause of vaccine-preventable childhood mortality. Worldwide, the fatality rate has been significantly reduced by a vaccination campaign led by partners in the Measles Initiative: the American Red Cross, the United States CDC, the United Nations Foundation, UNICEF and the WHO. Globally, measles fell 60% from an estimated 873,000 deaths in 1999 to 345,000 in 2005. Estimates for 2008 indicate deaths fell further to 164,000 globally, with 77% of the remaining measles deaths in 2008 occurring within the Southeast Asian region. There were 142,300 measles related deaths globally in 2018, of which most cases were reported from African and eastern Mediterranean regions. These estimates were slightly higher than that of 2017, when 124,000 deaths were reported due to measles infection globally.
In 2000, the WHO established the Global Measles and Rubella Laboratory Network (GMRLN) to provide laboratory surveillance for measles, rubella, and congenital rubella syndrome. Data from 2016 to 2018 show that the most frequently detected measles virus genotypes are decreasing, suggesting that increasing global population immunity has decreased the number of chains of transmission.
Cases reported in the first three months of 2019 were 300% higher than in the first three months of 2018, with outbreaks in every region of the world, even in countries with high overall vaccination coverage where it spread among clusters of unvaccinated people. The numbers of reported cases as of mid-November is over 413,000 globally, with an additional 250,000 cases in DRC (as reported through their national system), similar to the increasing trends of infection reported in the earlier months of 2019, compared to 2018. In 2019, the total number of cases worldwide climbed to 869,770. The number of cases reported for 2020 is lower compare to 2019. According to the WHO, the COVID-19 pandemic hindered vaccination campaigns in at least 68 countries, including in countries that were experiencing outbreaks, which caused increased risk of additional cases.
In 2022, there were an estimated 136,000 measles deaths globally, mostly among unvaccinated or under vaccinated children under the age of 5 years.
In February 2024, the World Health Organization said more than half of the world was at risk of a measles outbreak due to COVID-19 pandemic-related disruptions in that month. All the world regions have reported such outbreaks with the exception of the Americas, though these could still be expected to become hotspots in the future. Death rates during the outbreaks tend to be higher among poorer countries but middle-income nations are also heavily impacted, according to the WHO.
In November 2024, the WHO and CDC reported that measles cases increased by 20% in 2023, primarily due to insufficient vaccine coverage in the world's poorest and conflict-affected regions, increasing from about 8.6 to 10.3 million cases. Nearly half of the major outbreaks and 64% of the individual cases occurred in Africa.
In England and Wales, though deaths from measles were uncommon, they averaged about 500 per year in the 1940s. Deaths diminished with the improvement of medical care in the 1950s, but the incidence of the disease did not retreat until vaccination was introduced in the late 1960s. Wider coverage was achieved in the 1980s with the measles, mumps and rubella, MMR vaccine.
In 2013–14, there were almost 10,000 cases in 30 European countries. Most cases occurred in unvaccinated individuals and over 90% of cases occurred in Germany, Italy, Netherlands, Romania, and United Kingdom. Between October 2014 and March 2015, a measles outbreak in the German capital of Berlin resulted in at least 782 cases.
In 2016, a record low of 4,400 cases in Europe were reported. However, from 2017, a measles resurgence in Europe started to occur with numbers increasing in that year to 21,315 cases, with 35 deaths. In preliminary figures for 2018, reported cases in the region increased 3-fold to 82,596 in 47 countries, with 72 deaths; Ukraine had the most cases (53,218), with the highest incidence rates being in Ukraine (1209 cases per million), Serbia (579), Georgia (564) and Albania (500). The previous year (2017) saw an estimated measles vaccine coverage of 95% for the first dose and 90% for the second dose in the region, the latter figure being the highest-ever estimated second-dose coverage.
In 2019, the United Kingdom, Albania, the Czech Republic, and Greece lost their measles-free status due to ongoing and prolonged spread of the disease in these countries. In the first 6 months of 2019, 90,000 cases occurred in Europe.
A significant increase in measles cases in Europe occurred in 2024, with 127,350 being reported. This was the highest caseload in the region since 1997, representing a third of global measles cases.
The major centre of the resurgent outbreak appeared to be Romania where 30,692 cases were reported.
As a result of widespread vaccination, the disease was declared eliminated from the Americas in 2016. However, there were cases again in 2017, 2018, 2019, and 2020 in this region.
In the United States, measles affected approximately 3,000 people per million in the 1960s before the vaccine was available. With consistent widespread childhood vaccination, this figure fell to 13 cases per million by the 1980s, and to about 1 case per million by 2000.
Before immunization in the United States, between three and four million cases occurred each year. The United States was declared free of circulating measles in 2000, with 911 cases from 2001 to 2011. In 2014 the CDC said endemic measles, rubella, and congenital rubella syndrome had not returned to the United States. Occasional measles outbreaks persist, however, because of cases imported from abroad, of which more than half are the result of unvaccinated U.S. residents who are infected abroad and infect others upon return to the United States. The CDC continues to recommend measles vaccination throughout the population to prevent outbreaks like these.
From 4 January, to 2 April 2015, there were 159 cases of measles reported to the CDC. Of those 159 cases, 111 (70%) were determined to have come from an earlier exposure in late December 2014. This outbreak was believed to have originated from the Disneyland theme park in California. The Disneyland outbreak was held responsible for the infection of 147 people in seven U.S. states as well as Mexico and Canada, the majority of which were either unvaccinated or had unknown vaccination status. Of the cases 48% were unvaccinated and 38% were unsure of their vaccination status. The initial exposure to the virus was never identified.
In June 2017, the Maine Health and Environmental Testing Laboratory confirmed a case of measles in Franklin County. This instance marks the first case of measles in 20 years for the state of Maine. In 2018, one case occurred in Portland, Oregon, with 500 people exposed; 40 of them lacked immunity to the virus and were being monitored by county health officials as of 2 July 2018. There were 273 cases of measles reported throughout the United States in 2018, including an outbreak in Brooklyn with more than 200 reported cases from October 2018 to February 2019. The outbreak was tied with population density of the Orthodox Jewish community, with the initial exposure from an unvaccinated child that caught measles while visiting Israel.
The spread of measles had been interrupted in Brazil in 2016, with the last-known case twelve months earlier. This last case was in the state of Ceará.
In the Vietnamese measles epidemic in spring of 2014, an estimated 8,500 measles cases were reported as of 19 April, with 114 fatalities; as of 30 May, 21,639 suspected measles cases had been reported, with 142 measles-related fatalities. In the Naga Self-Administered Zone in a remote northern region of Myanmar, at least 40 children died during a measles outbreak in August 2016 that was probably caused by lack of vaccination in an area of poor health infrastructure. Following the 2019 Philippines measles outbreak, 23,563 measles cases have been reported in the country with 338 fatalities. A measles outbreak also happened among the Malaysian Orang Asli sub-group of Batek people in the state of Kelantan from May 2019, causing the deaths of 15 from the tribe. In 2024, a measles outbreak was declared in the Bangsamoro region in the Philippines with at least 592 cases and 3 deaths.
The Democratic Republic of the Congo and Madagascar have reported the highest numbers of cases in 2019. However, cases have decreased in Madagascar as a result of nationwide emergency measles vaccine campaigns. As of August 2019 outbreaks were occurring in Angola, Cameroon, Chad, Nigeria, South Sudan and Sudan.
Prior to the introduction of vaccines, more than 2 million deaths and 30 million cases were estimated to occur annually around the world. In 1954, John Enders and Thomas C. Peebles isolated the measles virus from a 13-year-old boy from the United States, David Edmonston. Enders was one of the researchers experienced with propagating poliovirus, paving the way for the Salk vaccine, and used similar techniques to grow the Edmonston strain in human kidney tissue, then amniotic membrane tissue culture, and finally chick embryo culture. This created a virus capable of replicating and generating immunity, but not of causing disease, a process called attenuation. While at Merck, Maurice Hilleman used the Edmonston B strain to develop the first successful measles vaccine, which became widely available in the United States in 1963. An improved measles vaccine became available in 1968. The measles vaccine was combined with the mumps vaccine and rubella vaccine, which are similar live vaccines given at the same ages, to create the MMR vaccine. It was licensed for use in the United States in 1971. The MMR vaccine was combined with the varicella vaccine to create the MMRV vaccine, which was licensed in 2005.
As outbreaks easily occur in under-vaccinated populations, the disease is seen as a test of sufficient vaccination within a population. Measles outbreaks have been on the rise in the United States, especially in communities with lower rates of vaccination. A different vaccine distribution within a single territory by age or social class may define different general perceptions of vaccination efficacy. It is often introduced to a region by travelers from other countries and it typically spreads to those who have not received the measles vaccination.
Douglas Harper (n.d.). "measles (n.)". Online Etymology Dictionary. Archived from the original on 14 September 2024. Retrieved 14 September 2024. https://www.etymonline.com/word/measles#etymonline_v_12498
"measles". Oxford English Dictionary. Archived from the original on 20 September 2023. Retrieved 10 April 2025. https://www.oed.com/dictionary/measles_n
Tesini BL (July 2023). "Measles". Merck Manual Professional. Archived from the original on 8 April 2025. Retrieved 10 April 2025. https://www.merckmanuals.com/professional/pediatrics/common-viral-infections-in-infants-and-children/measles
"Chapter 13: Measles". Pink Book Epidemiology and Prevention of Vaccine-Preventable Diseases. U.S. Centers for Disease Control and Prevention (CDC). 24 April 2024. Archived from the original on 19 July 2024. Retrieved 9 April 2025. https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-13-measles.html
Milner DA (2015). Diagnostic Pathology: Infectious Diseases E-Book. Elsevier Health Sciences. p. 24. ISBN 978-0-323-40037-4. Archived from the original on 8 September 2017. 978-0-323-40037-4
Tesini BL (July 2023). "Measles". Merck Manual Professional. Archived from the original on 8 April 2025. Retrieved 10 April 2025. https://www.merckmanuals.com/professional/pediatrics/common-viral-infections-in-infants-and-children/measles
"Measles Fact Sheet". World Health Organization (WHO). 14 November 2024. Archived from the original on 28 November 2022. Retrieved 10 April 2025. https://www.who.int/en/news-room/fact-sheets/detail/measles
Tesini BL (July 2023). "Measles". Merck Manual Professional. Archived from the original on 8 April 2025. Retrieved 10 April 2025. https://www.merckmanuals.com/professional/pediatrics/common-viral-infections-in-infants-and-children/measles
"Measles (Rubeola) Signs and Symptoms". U.S. Centers for Disease Control and Prevention (CDC). 3 November 2014. Archived from the original on 2 February 2015. Retrieved 5 February 2015. https://web.archive.org/web/20150202192809/http://www.cdc.gov/measles/about/signs-symptoms.html
"Measles (Rubeola) Signs and Symptoms". U.S. Centers for Disease Control and Prevention (CDC). 3 November 2014. Archived from the original on 2 February 2015. Retrieved 5 February 2015. https://web.archive.org/web/20150202192809/http://www.cdc.gov/measles/about/signs-symptoms.html
"Measles (Rubeola) Signs and Symptoms". U.S. Centers for Disease Control and Prevention (CDC). 3 November 2014. Archived from the original on 2 February 2015. Retrieved 5 February 2015. https://web.archive.org/web/20150202192809/http://www.cdc.gov/measles/about/signs-symptoms.html
"Chapter 13: Measles". Pink Book Epidemiology and Prevention of Vaccine-Preventable Diseases. U.S. Centers for Disease Control and Prevention (CDC). 24 April 2024. Archived from the original on 19 July 2024. Retrieved 9 April 2025. https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-13-measles.html
Rota PA, Moss WJ, Takeda M, de Swart RL, Thompson KM, Goodson JL (July 2016). "Measles". Nature Reviews. Disease Primers. 2: 16049. doi:10.1038/nrdp.2016.49. PMID 27411684. https://doi.org/10.1038%2Fnrdp.2016.49
"Chapter 13: Measles". Pink Book Epidemiology and Prevention of Vaccine-Preventable Diseases. U.S. Centers for Disease Control and Prevention (CDC). 24 April 2024. Archived from the original on 19 July 2024. Retrieved 9 April 2025. https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-13-measles.html
"Measles Fact Sheet". World Health Organization (WHO). 14 November 2024. Archived from the original on 28 November 2022. Retrieved 10 April 2025. https://www.who.int/en/news-room/fact-sheets/detail/measles
"Measles Fact Sheet". World Health Organization (WHO). 14 November 2024. Archived from the original on 28 November 2022. Retrieved 10 April 2025. https://www.who.int/en/news-room/fact-sheets/detail/measles
"Measles Fact Sheet". World Health Organization (WHO). 14 November 2024. Archived from the original on 28 November 2022. Retrieved 10 April 2025. https://www.who.int/en/news-room/fact-sheets/detail/measles
Guerra FM, Bolotin S, Lim G, Heffernan J, Deeks SL, Li Y, et al. (December 2017). "The basic reproduction number (R0) of measles: a systematic review". The Lancet. Infectious Diseases. 17 (12): e420 – e428. doi:10.1016/S1473-3099(17)30307-9. ISSN 1474-4457. PMID 28757186. /wiki/Doi_(identifier)
Delamater PL, Street EJ, Leslie TF, Yang YT, Jacobsen KH (2019). "Complexity of the Basic Reproduction Number (R0)". Emerging Infectious Diseases. 25 (1). NIH website: 1–4. doi:10.3201/eid2501.171901. PMC 6302597. PMID 30560777. [a] review in 2017 identified feasible measles R0 values of 3.7–203.3 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302597
"Chapter 13: Measles". Pink Book Epidemiology and Prevention of Vaccine-Preventable Diseases. U.S. Centers for Disease Control and Prevention (CDC). 24 April 2024. Archived from the original on 19 July 2024. Retrieved 9 April 2025. https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-13-measles.html
Selina SP, Chen MD (6 June 2019). Measles (Report). Medscape. Archived from the original on 25 September 2011. https://emedicine.medscape.com/article/966220-overview
"Measles Fact Sheet". World Health Organization (WHO). 14 November 2024. Archived from the original on 28 November 2022. Retrieved 10 April 2025. https://www.who.int/en/news-room/fact-sheets/detail/measles
"Chapter 13: Measles". Pink Book Epidemiology and Prevention of Vaccine-Preventable Diseases. U.S. Centers for Disease Control and Prevention (CDC). 24 April 2024. Archived from the original on 19 July 2024. Retrieved 9 April 2025. https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-13-measles.html
"Measles". World Health Organization (WHO). Archived from the original on 30 April 2025. Retrieved 30 April 2025. https://www.who.int/news-room/fact-sheets/detail/measles
"Measles Fact Sheet". World Health Organization (WHO). 14 November 2024. Archived from the original on 28 November 2022. Retrieved 10 April 2025. https://www.who.int/en/news-room/fact-sheets/detail/measles
"Measles Fact Sheet". World Health Organization (WHO). 14 November 2024. Archived from the original on 28 November 2022. Retrieved 10 April 2025. https://www.who.int/en/news-room/fact-sheets/detail/measles
Bope ET, Kellerman RD (2014). Conn's Current Therapy 2015. Elsevier Health Sciences. p. 153. ISBN 978-0-323-31956-0. Archived from the original on 8 September 2017. 978-0-323-31956-0
"Measles Fact Sheet". World Health Organization (WHO). 14 November 2024. Archived from the original on 28 November 2022. Retrieved 10 April 2025. https://www.who.int/en/news-room/fact-sheets/detail/measles
"Measles". World Health Organization (WHO). Archived from the original on 30 April 2025. Retrieved 30 April 2025. https://www.who.int/news-room/fact-sheets/detail/measles
"Measles Fact Sheet". World Health Organization (WHO). 14 November 2024. Archived from the original on 28 November 2022. Retrieved 10 April 2025. https://www.who.int/en/news-room/fact-sheets/detail/measles
"Chapter 13: Measles". Pink Book Epidemiology and Prevention of Vaccine-Preventable Diseases. U.S. Centers for Disease Control and Prevention (CDC). 24 April 2024. Archived from the original on 19 July 2024. Retrieved 9 April 2025. https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-13-measles.html
"Measles Fact Sheet". World Health Organization (WHO). 14 November 2024. Archived from the original on 28 November 2022. Retrieved 10 April 2025. https://www.who.int/en/news-room/fact-sheets/detail/measles
"Measles Fact Sheet". World Health Organization (WHO). 14 November 2024. Archived from the original on 28 November 2022. Retrieved 10 April 2025. https://www.who.int/en/news-room/fact-sheets/detail/measles
"Measles Fact Sheet". World Health Organization (WHO). 14 November 2024. Archived from the original on 28 November 2022. Retrieved 10 April 2025. https://www.who.int/en/news-room/fact-sheets/detail/measles
Russell SJ, Babovic-Vuksanovic D, Bexon A, Cattaneo R, Dingli D, Dispenzieri A, et al. (September 2019). "Oncolytic Measles Virotherapy and Opposition to Measles Vaccination". Mayo Clinic Proceedings. 94 (9): 1834–39. doi:10.1016/j.mayocp.2019.05.006. PMC 6800178. PMID 31235278. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6800178
Ludlow M, McQuaid S, Milner D, de Swart RL, Duprex WP (January 2015). "Pathological consequences of systemic measles virus infection". The Journal of Pathology. 235 (2): 253–65. doi:10.1002/path.4457. PMID 25294240. https://doi.org/10.1002%2Fpath.4457
"Measles Fact Sheet". World Health Organization (WHO). 14 November 2024. Archived from the original on 28 November 2022. Retrieved 10 April 2025. https://www.who.int/en/news-room/fact-sheets/detail/measles
Tesini BL (July 2023). "Measles". Merck Manual Professional. Archived from the original on 8 April 2025. Retrieved 10 April 2025. https://www.merckmanuals.com/professional/pediatrics/common-viral-infections-in-infants-and-children/measles
"Measles Fact Sheet". World Health Organization (WHO). 14 November 2024. Archived from the original on 28 November 2022. Retrieved 10 April 2025. https://www.who.int/en/news-room/fact-sheets/detail/measles
Kabra SK, Lodha R (August 2013). "Antibiotics for preventing complications in children with measles". The Cochrane Database of Systematic Reviews. 2013 (8): CD001477. doi:10.1002/14651858.CD001477.pub4. PMC 7055587. PMID 23943263. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055587
"Despite the availability of a safe, effective and inexpensive vaccine for more than 40 years, measles remains a leading vaccine-preventable cause of childhood deaths" (PDF). Archived from the original (PDF) on 12 December 2019. Retrieved 16 February 2019. https://web.archive.org/web/20191212171454/https://www.who.int/immunization/newsroom/MI_Fact%20Sheet_17_jan_2007.pdf
"Measles Fact Sheet". World Health Organization (WHO). 14 November 2024. Archived from the original on 28 November 2022. Retrieved 10 April 2025. https://www.who.int/en/news-room/fact-sheets/detail/measles
GBD 2015 Mortality and Causes of Death Collaborators (October 2016). "Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1459–1544. doi:10.1016/S0140-6736(16)31012-1. PMC 5388903. PMID 27733281. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388903
GBD 2013 Mortality Causes of Death Collaborators (January 2015). "Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013". Lancet. 385 (9963): 117–71. doi:10.1016/S0140-6736(14)61682-2. PMC 4340604. PMID 25530442. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340604
"Measles cases spike globally due to gaps in vaccination coverage". World Health Organization (WHO). 29 November 2018. Archived from the original on 24 December 2018. Retrieved 21 December 2018. https://www.who.int/news-room/detail/29-11-2018-measles-cases-spike-globally-due-to-gaps-in-vaccination-coverage
"U.S. measles cases surge nearly 20 percent in early April, CDC says". Reuters. 16 April 2019. Archived from the original on 15 April 2019. Retrieved 16 April 2019. https://www.reuters.com/article/us-usa-measles/measles-cases-in-u-s-surge-nearly-20-in-early-april-cdc-says-idUSKCN1RR1H4
"Measles – European Region". World Health Organization (WHO). Archived from the original on 8 May 2019. Retrieved 8 May 2019. https://web.archive.org/web/20190508120456/https://www.who.int/csr/don/06-may-2019-measles-euro/en/
"Chapter 13: Measles". Pink Book Epidemiology and Prevention of Vaccine-Preventable Diseases. U.S. Centers for Disease Control and Prevention (CDC). 24 April 2024. Archived from the original on 19 July 2024. Retrieved 9 April 2025. https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-13-measles.html
Tesini BL (July 2023). "Measles". Merck Manual Professional. Archived from the original on 8 April 2025. Retrieved 10 April 2025. https://www.merckmanuals.com/professional/pediatrics/common-viral-infections-in-infants-and-children/measles
Rota PA, Moss WJ, Takeda M, de Swart RL, Thompson KM, Goodson JL (July 2016). "Measles". Nature Reviews. Disease Primers. 2: 16049. doi:10.1038/nrdp.2016.49. PMID 27411684. https://doi.org/10.1038%2Fnrdp.2016.49
"Chapter 13: Measles". Pink Book Epidemiology and Prevention of Vaccine-Preventable Diseases. U.S. Centers for Disease Control and Prevention (CDC). 24 April 2024. Archived from the original on 19 July 2024. Retrieved 9 April 2025. https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-13-measles.html
Tesini BL (July 2023). "Measles". Merck Manual Professional. Archived from the original on 8 April 2025. Retrieved 10 April 2025. https://www.merckmanuals.com/professional/pediatrics/common-viral-infections-in-infants-and-children/measles
Biesbroeck L, Sidbury R (November 2013). "Viral exanthems: an update". Dermatologic Therapy. 26 (6): 433–8. doi:10.1111/dth.12107. PMID 24552405. S2CID 10496269. https://doi.org/10.1111%2Fdth.12107
"Chapter 13: Measles". Pink Book Epidemiology and Prevention of Vaccine-Preventable Diseases. U.S. Centers for Disease Control and Prevention (CDC). 24 April 2024. Archived from the original on 19 July 2024. Retrieved 9 April 2025. https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-13-measles.html
Rota PA, Moss WJ, Takeda M, de Swart RL, Thompson KM, Goodson JL (July 2016). "Measles". Nature Reviews. Disease Primers. 2: 16049. doi:10.1038/nrdp.2016.49. PMID 27411684. https://doi.org/10.1038%2Fnrdp.2016.49
Rota PA, Moss WJ, Takeda M, de Swart RL, Thompson KM, Goodson JL (July 2016). "Measles". Nature Reviews. Disease Primers. 2: 16049. doi:10.1038/nrdp.2016.49. PMID 27411684. https://doi.org/10.1038%2Fnrdp.2016.49
Rota PA, Moss WJ, Takeda M, de Swart RL, Thompson KM, Goodson JL (July 2016). "Measles". Nature Reviews. Disease Primers. 2: 16049. doi:10.1038/nrdp.2016.49. PMID 27411684. https://doi.org/10.1038%2Fnrdp.2016.49
"Chapter 13: Measles". Pink Book Epidemiology and Prevention of Vaccine-Preventable Diseases. U.S. Centers for Disease Control and Prevention (CDC). 24 April 2024. Archived from the original on 19 July 2024. Retrieved 9 April 2025. https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-13-measles.html
Rota PA, Moss WJ, Takeda M, de Swart RL, Thompson KM, Goodson JL (July 2016). "Measles". Nature Reviews. Disease Primers. 2: 16049. doi:10.1038/nrdp.2016.49. PMID 27411684. https://doi.org/10.1038%2Fnrdp.2016.49
Rota PA, Moss WJ, Takeda M, de Swart RL, Thompson KM, Goodson JL (July 2016). "Measles". Nature Reviews. Disease Primers. 2: 16049. doi:10.1038/nrdp.2016.49. PMID 27411684. https://doi.org/10.1038%2Fnrdp.2016.49
Griffin DE (July 2010). "Measles virus-induced suppression of immune responses". Immunological Reviews. 236: 176–89. doi:10.1111/j.1600-065X.2010.00925.x. PMC 2908915. PMID 20636817. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2908915
Griffin AH (18 May 2019). "Measles and Immune Amnesia". asm.org. American Society for Microbiology. Archived from the original on 18 January 2020. Retrieved 18 January 2020. https://asm.org/Articles/2019/May/Measles-and-Immune-Amnesia
Mina MJ, Kula T, Leng Y, Li M, de Vries RD, Knip M, et al. (1 November 2019). "Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens". Science. 366 (6465): 599–606. Bibcode:2019Sci...366..599M. doi:10.1126/science.aay6485. hdl:10138/307628. ISSN 0036-8075. PMC 8590458. PMID 31672891. https://doi.org/10.1126%2Fscience.aay6485
Guglielmi G (31 October 2019). "Measles erases immune 'memory' for other diseases". Nature. doi:10.1038/d41586-019-03324-7. PMID 33122832. S2CID 208489179. Archived from the original on 2 November 2019. Retrieved 3 November 2019. https://www.nature.com/articles/d41586-019-03324-7
Griffin AH (18 May 2019). "Measles and Immune Amnesia". asm.org. American Society for Microbiology. Archived from the original on 18 January 2020. Retrieved 18 January 2020. https://asm.org/Articles/2019/May/Measles-and-Immune-Amnesia
Fisher DL, Defres S, Solomon T (March 2015). "Measles-induced encephalitis". QJM. 108 (3): 177–82. doi:10.1093/qjmed/hcu113. PMID 24865261. https://doi.org/10.1093%2Fqjmed%2Fhcu113
Semba RD, Bloem MW (March 2004). "Measles blindness". Survey of Ophthalmology. 49 (2): 243–55. doi:10.1016/j.survophthal.2003.12.005. PMID 14998696. /wiki/Doi_(identifier)
Rota PA, Moss WJ, Takeda M, de Swart RL, Thompson KM, Goodson JL (July 2016). "Measles". Nature Reviews. Disease Primers. 2: 16049. doi:10.1038/nrdp.2016.49. PMID 27411684. https://doi.org/10.1038%2Fnrdp.2016.49
Ellison JB (February 1931). "Pneumonia in Measles". Archives of Disease in Childhood. 6 (31): 37–52. doi:10.1136/adc.6.31.37. PMC 1975146. PMID 21031836. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1975146
Selina SP, Chen MD (6 June 2019). Measles (Report). Medscape. Archived from the original on 25 September 2011. https://emedicine.medscape.com/article/966220-overview
Selina SP, Chen MD (6 June 2019). Measles (Report). Medscape. Archived from the original on 25 September 2011. https://emedicine.medscape.com/article/966220-overview
Selina SP, Chen MD (6 June 2019). Measles (Report). Medscape. Archived from the original on 25 September 2011. https://emedicine.medscape.com/article/966220-overview
Selina SP, Chen MD (6 June 2019). Measles (Report). Medscape. Archived from the original on 25 September 2011. https://emedicine.medscape.com/article/966220-overview
"Measles". U.S. Centers for Disease Control and Prevention (CDC). Archived from the original on 23 October 2016. Retrieved 22 October 2016. https://www.cdc.gov/measles/hcp/clinical-overview/
Selina SP, Chen MD (6 June 2019). Measles (Report). Medscape. Archived from the original on 25 September 2011. https://emedicine.medscape.com/article/966220-overview
Selina SP, Chen MD (6 June 2019). Measles (Report). Medscape. Archived from the original on 25 September 2011. https://emedicine.medscape.com/article/966220-overview
National Institutes of Health Office of Dietary Supplements (2013). "Vitamin A". U.S. Department of Health & Human Services. Archived from the original on 11 March 2015. Retrieved 11 March 2015. https://ods.od.nih.gov/factsheets/VitaminA-HealthProfessional/
Sabella C (March 2010). "Measles: not just a childhood rash". Cleveland Clinic Journal of Medicine. 77 (3): 207–13. doi:10.3949/ccjm.77a.09123. PMID 20200172. S2CID 4743168. https://doi.org/10.3949%2Fccjm.77a.09123
Perry RT, Halsey NA (May 2004). "The clinical significance of measles: a review". The Journal of Infectious Diseases. 189 Suppl 1 (S1): S4-16. doi:10.1086/377712. PMID 15106083. https://doi.org/10.1086%2F377712
Perry RT, Halsey NA (May 2004). "The clinical significance of measles: a review". The Journal of Infectious Diseases. 189 Suppl 1 (S1): S4-16. doi:10.1086/377712. PMID 15106083. https://doi.org/10.1086%2F377712
Sension MG, Quinn TC, Markowitz LE, Linnan MJ, Jones TS, Francis HL, et al. (December 1988). "Measles in hospitalized African children with human immunodeficiency virus". American Journal of Diseases of Children. 142 (12): 1271–2. doi:10.1001/archpedi.1988.02150120025021. PMID 3195521. /wiki/Doi_(identifier)
"Measles". U.S. Centers for Disease Control and Prevention (CDC). Archived from the original on 23 October 2016. Retrieved 22 October 2016. https://www.cdc.gov/measles/hcp/clinical-overview/
"Measles". U.S. Centers for Disease Control and Prevention (CDC). Archived from the original on 23 October 2016. Retrieved 22 October 2016. https://www.cdc.gov/measles/hcp/clinical-overview/
"Measles". U.S. Centers for Disease Control and Prevention (CDC). Archived from the original on 23 October 2016. Retrieved 22 October 2016. https://www.cdc.gov/measles/hcp/clinical-overview/
Hübschen JM, Gouandjika-Vasilache I, Dina J (12 February 2022). "Measles". Lancet. 399 (10325): 678–690. doi:10.1016/S0140-6736(21)02004-3. ISSN 1474-547X. PMID 35093206. https://pubmed.ncbi.nlm.nih.gov/35093206
Bester JC (December 2016). "Measles and Measles Vaccination: A Review". JAMA Pediatrics. 170 (12): 1209–15. doi:10.1001/jamapediatrics.2016.1787. ISSN 2168-6203. PMID 27695849. /wiki/Doi_(identifier)
"Chapter 13: Measles". Pink Book Epidemiology and Prevention of Vaccine-Preventable Diseases. U.S. Centers for Disease Control and Prevention (CDC). 24 April 2024. Archived from the original on 19 July 2024. Retrieved 9 April 2025. https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-13-measles.html
Hübschen JM, Gouandjika-Vasilache I, Dina J (12 February 2022). "Measles". Lancet. 399 (10325): 678–690. doi:10.1016/S0140-6736(21)02004-3. ISSN 1474-547X. PMID 35093206. https://pubmed.ncbi.nlm.nih.gov/35093206
"Measles". U.S. Centers for Disease Control and Prevention (CDC). Archived from the original on 23 October 2016. Retrieved 22 October 2016. https://www.cdc.gov/measles/hcp/clinical-overview/
Bester JC (December 2016). "Measles and Measles Vaccination: A Review". JAMA Pediatrics. 170 (12): 1209–15. doi:10.1001/jamapediatrics.2016.1787. ISSN 2168-6203. PMID 27695849. /wiki/Doi_(identifier)
Hübschen JM, Gouandjika-Vasilache I, Dina J (12 February 2022). "Measles". Lancet. 399 (10325): 678–690. doi:10.1016/S0140-6736(21)02004-3. ISSN 1474-547X. PMID 35093206. https://pubmed.ncbi.nlm.nih.gov/35093206
"Chapter 13: Measles". Pink Book Epidemiology and Prevention of Vaccine-Preventable Diseases. U.S. Centers for Disease Control and Prevention (CDC). 24 April 2024. Archived from the original on 19 July 2024. Retrieved 9 April 2025. https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-13-measles.html
Rota PA, Moss WJ, Takeda M, de Swart RL, Thompson KM, Goodson JL (July 2016). "Measles". Nature Reviews. Disease Primers. 2: 16049. doi:10.1038/nrdp.2016.49. PMID 27411684. https://doi.org/10.1038%2Fnrdp.2016.49
"Chapter 13: Measles". Pink Book Epidemiology and Prevention of Vaccine-Preventable Diseases. U.S. Centers for Disease Control and Prevention (CDC). 24 April 2024. Archived from the original on 19 July 2024. Retrieved 9 April 2025. https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-13-measles.html
"Chapter 13: Measles". Pink Book Epidemiology and Prevention of Vaccine-Preventable Diseases. U.S. Centers for Disease Control and Prevention (CDC). 24 April 2024. Archived from the original on 19 July 2024. Retrieved 9 April 2025. https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-13-measles.html
Banerjee E, Griffith J, Kenyon C, Christianson B, Strain A, Martin K, et al. (2020). "Containing a measles outbreak in Minnesota, 2017: methods and challenges". Perspect Public Health. 140 (3): 162–171. doi:10.1177/1757913919871072. PMID 31480896. S2CID 201829328. Archived from the original on 2 May 2023. https://pubmed.ncbi.nlm.nih.gov/31480896
"Chapter 13: Measles". Pink Book Epidemiology and Prevention of Vaccine-Preventable Diseases. U.S. Centers for Disease Control and Prevention (CDC). 24 April 2024. Archived from the original on 19 July 2024. Retrieved 9 April 2025. https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-13-measles.html
Spelman LH, Gilardi KV, Lukasik-Braum M, Kinani JF, Nyirakaragire E, Lowenstine LJ, et al. (2013). "Respiratory disease in mountain gorillas (Gorilla beringei beringei) in Rwanda, 1990-2010: outbreaks, clinical course, and medical management". J Zoo Wildl Med. 44 (4): 1027–35. doi:10.1638/2013-0014R.1. PMID 24450064. Archived from the original on 2 May 2023. https://pubmed.ncbi.nlm.nih.gov/24450064
Gowda VK, Sukanya V (November 2012). "Acquired immunodeficiency syndrome with subacute sclerosing panencephalitis". Pediatric Neurology. 47 (5): 379–81. doi:10.1016/j.pediatrneurol.2012.06.020. PMID 23044024. /wiki/Doi_(identifier)
Waggoner JJ, Soda EA, Deresinski S (October 2013). "Rare and emerging viral infections in transplant recipients". Clinical Infectious Diseases. 57 (8): 1182–8. doi:10.1093/cid/cit456. PMC 7107977. PMID 23839998. https://doi.org/10.1093%2Fcid%2Fcit456
Selina SP, Chen MD (6 June 2019). Measles (Report). Medscape. Archived from the original on 25 September 2011. https://emedicine.medscape.com/article/966220-overview
Selina SP, Chen MD (6 June 2019). Measles (Report). Medscape. Archived from the original on 25 September 2011. https://emedicine.medscape.com/article/966220-overview
Leuridan E, Sabbe M, Van Damme P (September 2012). "Measles outbreak in Europe: susceptibility of infants too young to be immunized". Vaccine. 30 (41): 5905–13. doi:10.1016/j.vaccine.2012.07.035. PMID 22841972. /wiki/Doi_(identifier)
"Chapter 13: Measles". Pink Book Epidemiology and Prevention of Vaccine-Preventable Diseases. U.S. Centers for Disease Control and Prevention (CDC). 24 April 2024. Archived from the original on 19 July 2024. Retrieved 9 April 2025. https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-13-measles.html
Hübschen JM, Gouandjika-Vasilache I, Dina J (12 February 2022). "Measles". Lancet. 399 (10325): 678–690. doi:10.1016/S0140-6736(21)02004-3. ISSN 1474-547X. PMID 35093206. https://pubmed.ncbi.nlm.nih.gov/35093206
"Chapter 13: Measles". Pink Book Epidemiology and Prevention of Vaccine-Preventable Diseases. U.S. Centers for Disease Control and Prevention (CDC). 24 April 2024. Archived from the original on 19 July 2024. Retrieved 9 April 2025. https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-13-measles.html
"Chapter 13: Measles". Pink Book Epidemiology and Prevention of Vaccine-Preventable Diseases. U.S. Centers for Disease Control and Prevention (CDC). 24 April 2024. Archived from the original on 19 July 2024. Retrieved 9 April 2025. https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-13-measles.html
Rota PA, Moss WJ, Takeda M, de Swart RL, Thompson KM, Goodson JL (July 2016). "Measles". Nature Reviews. Disease Primers. 2: 16049. doi:10.1038/nrdp.2016.49. PMID 27411684. https://doi.org/10.1038%2Fnrdp.2016.49
Rainwater-Lovett K, Moss WJ (2018), Jameson JL, Fauci AS, Kasper DL, Hauser SL (eds.), "Measles (Rubeola)", Harrison's Principles of Internal Medicine (20 ed.), New York, NY: McGraw-Hill Education, archived from the original on 24 September 2020, retrieved 7 December 2020 https://accessmedicine.mhmedical.com/content.aspx?bookid=2129§ionid=192025856
Baxby D (July 1997). "The diagnosis of the invasion of measles from a study of the exanthema as it appears on the buccal mucous membraneBy Henry Koplik, M.D. Reproduced from Arch. Paed. 13, 918-922 (1886)". Reviews in Medical Virology. 7 (2): 71–74. doi:10.1002/(SICI)1099-1654(199707)7:2<71::AID-RMV185>3.0.CO;2-S. PMID 10398471. S2CID 42670134. /wiki/Derrick_Baxby
Rota PA, Moss WJ, Takeda M, de Swart RL, Thompson KM, Goodson JL (July 2016). "Measles". Nature Reviews. Disease Primers. 2: 16049. doi:10.1038/nrdp.2016.49. PMID 27411684. https://doi.org/10.1038%2Fnrdp.2016.49
"Chapter 13: Measles". Pink Book Epidemiology and Prevention of Vaccine-Preventable Diseases. U.S. Centers for Disease Control and Prevention (CDC). 24 April 2024. Archived from the original on 19 July 2024. Retrieved 9 April 2025. https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-13-measles.html
"Surveillance Manual | Measles | Vaccine Preventable Diseases". U.S. Centers for Disease Control and Prevention (CDC). 23 May 2019. Archived from the original on 4 August 2020. Retrieved 25 November 2019. https://www.cdc.gov/vaccines/pubs/surv-manual/chpt07-measles.html
Friedman M, Hadari I, Goldstein V, Sarov I (October 1983). "Virus-specific secretory IgA antibodies as a means of rapid diagnosis of measles and mumps infection". Israel Journal of Medical Sciences. 19 (10): 881–4. PMID 6662670. /wiki/PMID_(identifier)
"Surveillance Manual | Measles | Vaccine Preventable Diseases". U.S. Centers for Disease Control and Prevention (CDC). 23 May 2019. Archived from the original on 4 August 2020. Retrieved 25 November 2019. https://www.cdc.gov/vaccines/pubs/surv-manual/chpt07-measles.html
Friedman M, Hadari I, Goldstein V, Sarov I (October 1983). "Virus-specific secretory IgA antibodies as a means of rapid diagnosis of measles and mumps infection". Israel Journal of Medical Sciences. 19 (10): 881–4. PMID 6662670. /wiki/PMID_(identifier)
Dimech W, Mulders MN (July 2016). "A review of testing used in seroprevalence studies on measles and rubella". Vaccine. 34 (35): 4119–4122. doi:10.1016/j.vaccine.2016.06.006. PMID 27340096. /wiki/Doi_(identifier)
Simon JK, Ramirez K, Cuberos L, Campbell JD, Viret JF, Muñoz A, et al. (March 2011). "Mucosal IgA Responses in Healthy Adult Volunteers following Intranasal Spray Delivery of a Live Attenuated Measles Vaccine". Clinical and Vaccine Immunology. 18 (3): 355–361. doi:10.1128/CVI.00354-10. PMC 3067370. PMID 21228137. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3067370
Dimech W, Mulders MN (July 2016). "A review of testing used in seroprevalence studies on measles and rubella". Vaccine. 34 (35): 4119–4122. doi:10.1016/j.vaccine.2016.06.006. PMID 27340096. /wiki/Doi_(identifier)
Simon JK, Ramirez K, Cuberos L, Campbell JD, Viret JF, Muñoz A, et al. (March 2011). "Mucosal IgA Responses in Healthy Adult Volunteers following Intranasal Spray Delivery of a Live Attenuated Measles Vaccine". Clinical and Vaccine Immunology. 18 (3): 355–361. doi:10.1128/CVI.00354-10. PMC 3067370. PMID 21228137. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3067370
Dimech W, Mulders MN (July 2016). "A review of testing used in seroprevalence studies on measles and rubella". Vaccine. 34 (35): 4119–4122. doi:10.1016/j.vaccine.2016.06.006. PMID 27340096. /wiki/Doi_(identifier)
Milner DA (2015). Diagnostic Pathology: Infectious Diseases E-Book. Elsevier Health Sciences. p. 24. ISBN 978-0-323-40037-4. Archived from the original on 8 September 2017. 978-0-323-40037-4
Weisenberg E (9 August 2022). "Measles". PathologyOutlines.com. Archived from the original on 30 June 2024. Retrieved 9 April 2025. https://www.pathologyoutlines.com/topic/lungnontumormeasles.html
Weisenberg E (9 August 2022). "Measles". PathologyOutlines.com. Archived from the original on 30 June 2024. Retrieved 9 April 2025. https://www.pathologyoutlines.com/topic/lungnontumormeasles.html
"Chapter 13: Measles". Pink Book Epidemiology and Prevention of Vaccine-Preventable Diseases. U.S. Centers for Disease Control and Prevention (CDC). 24 April 2024. Archived from the original on 19 July 2024. Retrieved 9 April 2025. https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-13-measles.html
Leuridan E, Sabbe M, Van Damme P (September 2012). "Measles outbreak in Europe: susceptibility of infants too young to be immunized". Vaccine. 30 (41): 5905–13. doi:10.1016/j.vaccine.2012.07.035. PMID 22841972. /wiki/Doi_(identifier)
Tesini BL (July 2023). "Measles". Merck Manual Professional. Archived from the original on 8 April 2025. Retrieved 10 April 2025. https://www.merckmanuals.com/professional/pediatrics/common-viral-infections-in-infants-and-children/measles
Leuridan E, Sabbe M, Van Damme P (September 2012). "Measles outbreak in Europe: susceptibility of infants too young to be immunized". Vaccine. 30 (41): 5905–13. doi:10.1016/j.vaccine.2012.07.035. PMID 22841972. /wiki/Doi_(identifier)
"Management of Obstetric–Gynecologic Patients During a Measles Outbreak". www.acog.org. Retrieved 21 March 2025. https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2024/03/management-of-obstetric-gynecologic-patients-during-a-measles-outbreak
Leuridan E, Sabbe M, Van Damme P (September 2012). "Measles outbreak in Europe: susceptibility of infants too young to be immunized". Vaccine. 30 (41): 5905–13. doi:10.1016/j.vaccine.2012.07.035. PMID 22841972. /wiki/Doi_(identifier)
McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS (June 2013). "Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP)" (PDF). MMWR. Recommendations and Reports. 62 (RR-04): 2, 19. PMID 23760231. Archived (PDF) from the original on 13 April 2020. https://www.cdc.gov/mmwr/pdf/rr/rr6204.pdf
"Measles vaccines: WHO position paper". World Health Organization (WHO). 28 April 2017. Archived from the original on 14 February 2025. Retrieved 23 March 2025. https://www.who.int/teams/immunization-vaccines-and-biologicals/policies/position-papers/measles
Galindo BM, Concepción D, Galindo MA, Pérez A, Saiz J (January 2012). "Vaccine-related adverse events in Cuban children, 1999-2008". MEDICC Review. 14 (1): 38–43. doi:10.37757/MR2012V14.N1.8. PMID 22334111. https://doi.org/10.37757%2FMR2012V14.N1.8
"Measles vaccines: WHO position paper". World Health Organization (WHO). 28 April 2017. Archived from the original on 14 February 2025. Retrieved 23 March 2025. https://www.who.int/teams/immunization-vaccines-and-biologicals/policies/position-papers/measles
Helfand RF, Witte D, Fowlkes A, Garcia P, Yang C, Fudzulani R, et al. (November 2008). "Evaluation of the immune response to a 2-dose measles vaccination schedule administered at 6 and 9 months of age to HIV-infected and HIV-uninfected children in Malawi". The Journal of Infectious Diseases. 198 (10): 1457–65. doi:10.1086/592756. PMID 18828743. https://doi.org/10.1086%2F592756
Ołdakowska A, Marczyńska M (2008). "[Measles vaccination in HIV infected children]". Medycyna Wieku Rozwojowego. 12 (2 Pt 2): 675–80. PMID 19418943. /wiki/PMID_(identifier)
"Global goal to reduce measles deaths in children surpassed" (Press release). UNICEF. 2007. Archived from the original on 4 February 2015. Retrieved 11 March 2015. https://web.archive.org/web/20150204152400/http://www.unicef.org/media/media_38076.html
McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS (June 2013). "Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP)" (PDF). MMWR. Recommendations and Reports. 62 (RR-04): 2, 19. PMID 23760231. Archived (PDF) from the original on 13 April 2020. https://www.cdc.gov/mmwr/pdf/rr/rr6204.pdf
"Plan for Travel". Measles (Rubeola). 15 July 2024. Archived from the original on 28 April 2025. Retrieved 3 May 2025. https://www.cdc.gov/measles/travel/index.html
McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS (June 2013). "Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP)" (PDF). MMWR. Recommendations and Reports. 62 (RR-04): 2, 19. PMID 23760231. Archived (PDF) from the original on 13 April 2020. https://www.cdc.gov/mmwr/pdf/rr/rr6204.pdf
McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS (June 2013). "Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP)" (PDF). MMWR. Recommendations and Reports. 62 (RR-04): 2, 19. PMID 23760231. Archived (PDF) from the original on 13 April 2020. https://www.cdc.gov/mmwr/pdf/rr/rr6204.pdf
"Chapter 13: Measles". Pink Book Epidemiology and Prevention of Vaccine-Preventable Diseases. U.S. Centers for Disease Control and Prevention (CDC). 24 April 2024. Archived from the original on 19 July 2024. Retrieved 9 April 2025. https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-13-measles.html
"Measles Prevention: Recommendations of the Immunization Practices Advisory Committee (ACIP)". U.S. Centers for Disease Control and Prevention (CDC). 29 December 1989. Archived from the original on 15 May 2012. Retrieved 13 November 2020. https://www.cdc.gov/mmwr/preview/mmwrhtml/00041753.htm
Selina SP, Chen MD (6 June 2019). Measles (Report). Medscape. Archived from the original on 25 September 2011. https://emedicine.medscape.com/article/966220-overview
Russell SJ, Babovic-Vuksanovic D, Bexon A, Cattaneo R, Dingli D, Dispenzieri A, et al. (September 2019). "Oncolytic Measles Virotherapy and Opposition to Measles Vaccination". Mayo Clinic Proceedings. 94 (9): 1834–39. doi:10.1016/j.mayocp.2019.05.006. PMC 6800178. PMID 31235278. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6800178
Di Pietrantonj C, Rivetti A, Marchione P, Debalini MG, Demicheli V (22 November 2021). "Vaccines for measles, mumps, rubella, and varicella in children". The Cochrane Database of Systematic Reviews. 2021 (11): CD004407. doi:10.1002/14651858.CD004407.pub5. ISSN 1469-493X. PMC 8607336. PMID 34806766. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607336
Di Pietrantonj C, Rivetti A, Marchione P, Debalini MG, Demicheli V (22 November 2021). "Vaccines for measles, mumps, rubella, and varicella in children". The Cochrane Database of Systematic Reviews. 2021 (11): CD004407. doi:10.1002/14651858.CD004407.pub5. ISSN 1469-493X. PMC 8607336. PMID 34806766. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607336
Young MK, Nimmo GR, Cripps AW, Jones MA (April 2014). "Post-exposure passive immunisation for preventing measles". Cochrane Database of Systematic Reviews. 2014 (4): CD010056. doi:10.1002/14651858.cd010056.pub2. hdl:10072/65474. ISSN 1465-1858. PMC 11055624. PMID 24687262. https://doi.org/10.1002/14651858.CD010056.pub2
Young MK, Nimmo GR, Cripps AW, Jones MA (April 2014). "Post-exposure passive immunisation for preventing measles". Cochrane Database of Systematic Reviews. 2014 (4): CD010056. doi:10.1002/14651858.cd010056.pub2. hdl:10072/65474. ISSN 1465-1858. PMC 11055624. PMID 24687262. https://doi.org/10.1002/14651858.CD010056.pub2
"Measles". U.S. Centers for Disease Control and Prevention (CDC). Archived from the original on 23 October 2016. Retrieved 22 October 2016. https://www.cdc.gov/measles/hcp/clinical-overview/
Bester JC (December 2016). "Measles and Measles Vaccination: A Review". JAMA Pediatrics. 170 (12): 1209–15. doi:10.1001/jamapediatrics.2016.1787. ISSN 2168-6203. PMID 27695849. /wiki/Doi_(identifier)
Imdad A, Mayo-Wilson E, Haykal MR, Regan A, Sidhu J, Smith A, et al. (March 2022). "Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age". Cochrane Database Syst Rev. 3 (3): CD008524. doi:10.1002/14651858.CD008524.pub4. PMC 8925277. PMID 35294044. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925277
"Office of Dietary Supplements - Vitamin A and Carotenoids". ods.od.nih.gov. Archived from the original on 12 December 2016. Retrieved 8 April 2025. https://ods.od.nih.gov/factsheets/VitaminA-HealthProfessional/
Imdad A, Mayo-Wilson E, Haykal MR, Regan A, Sidhu J, Smith A, et al. (March 2022). "Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age". Cochrane Database Syst Rev. 3 (3): CD008524. doi:10.1002/14651858.CD008524.pub4. PMC 8925277. PMID 35294044. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925277
"Measles". U.S. Centers for Disease Control and Prevention (CDC). Archived from the original on 23 October 2016. Retrieved 22 October 2016. https://www.cdc.gov/measles/hcp/clinical-overview/
McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS (June 2013). "Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP)" (PDF). MMWR. Recommendations and Reports. 62 (RR-04): 2, 19. PMID 23760231. Archived (PDF) from the original on 13 April 2020. https://www.cdc.gov/mmwr/pdf/rr/rr6204.pdf
Bester JC (December 2016). "Measles and Measles Vaccination: A Review". JAMA Pediatrics. 170 (12): 1209–15. doi:10.1001/jamapediatrics.2016.1787. ISSN 2168-6203. PMID 27695849. /wiki/Doi_(identifier)
"Office of Dietary Supplements - Vitamin A and Carotenoids". ods.od.nih.gov. Archived from the original on 12 December 2016. Retrieved 8 April 2025. https://ods.od.nih.gov/factsheets/VitaminA-HealthProfessional/
"Office of Dietary Supplements - Vitamin A and Carotenoids". ods.od.nih.gov. Archived from the original on 12 December 2016. Retrieved 8 April 2025. https://ods.od.nih.gov/factsheets/VitaminA-HealthProfessional/
Bello S, Meremikwu MM, Ejemot-Nwadiaro RI, Oduwole O (August 2016). "Routine vitamin A supplementation for the prevention of blindness due to measles infection in children". Cochrane Database Systematic Review. doi:10.1002/14651858.CD007719.pub4. PMID 27580345. /wiki/Doi_(identifier)
Rosenbluth T (25 March 2025). "For Some Measles Patients, Vitamin A Remedy Supported by RFK Jr. Leaves Them More Ill". The New York Times. Archived from the original on 25 March 2025. Retrieved 26 March 2025. https://www.nytimes.com/2025/03/25/health/measles-kennedy-vitamin-a.html
"Office of Dietary Supplements - Vitamin A and Carotenoids". ods.od.nih.gov. Archived from the original on 12 December 2016. Retrieved 8 April 2025. https://ods.od.nih.gov/factsheets/VitaminA-HealthProfessional/
Rosenbluth T (25 March 2025). "For Some Measles Patients, Vitamin A Remedy Supported by RFK Jr. Leaves Them More Ill". The New York Times. Archived from the original on 25 March 2025. Retrieved 26 March 2025. https://www.nytimes.com/2025/03/25/health/measles-kennedy-vitamin-a.html
Davies DM (28 March 2025). "West Texas children treated for vitamin A toxicity as medical disinformation spreads alongside measles outbreak". TPR. Archived from the original on 19 April 2025. Retrieved 28 March 2025. https://www.tpr.org/public-health/2025-03-27/west-texas-children-treated-for-vitamin-a-toxicity-as-medical-disinformation-spreads-alongside-measles-outbreak
Fischman J (5 May 2025). "Do 'alternative' measles treatments touted by RFK Jr. work?". Scientific American. Retrieved 9 May 2025. https://www.scientificamerican.com/article/do-alternative-measles-treatments-touted-by-rfk-jr-work/
"Measles". U.S. Centers for Disease Control and Prevention (CDC). Archived from the original on 23 October 2016. Retrieved 22 October 2016. https://www.cdc.gov/measles/hcp/clinical-overview/
"Measles". U.S. Centers for Disease Control and Prevention (CDC). Archived from the original on 23 October 2016. Retrieved 22 October 2016. https://www.cdc.gov/measles/hcp/clinical-overview/
Rezaie SR. "Measles: The Sequel". Emergency Physicians Monthly. Archived from the original on 7 June 2019. Retrieved 7 June 2019. https://epmonthly.com/article/measles-the-sequel/
"Measles". U.S. Centers for Disease Control and Prevention (CDC). Archived from the original on 23 October 2016. Retrieved 22 October 2016. https://www.cdc.gov/measles/hcp/clinical-overview/
Bester JC (December 2016). "Measles and Measles Vaccination: A Review". JAMA Pediatrics. 170 (12): 1209–15. doi:10.1001/jamapediatrics.2016.1787. ISSN 2168-6203. PMID 27695849. /wiki/Doi_(identifier)
World Health Organization (April 2017). "Measles vaccines: WHO position paper – April 2017". Weekly Epidemiological Record. 92 (17): 205–27. hdl:10665/255377. PMID 28459148. /wiki/Hdl_(identifier)
"Frequently Asked Questions about Measles". Washington State Department of Health. Archived from the original on 5 August 2019. Retrieved 10 February 2019. [Vitamin A] cannot prevent or cure the measles https://www.doh.wa.gov/YouandYourFamily/IllnessandDisease/Measles/FrequentlyAskedQuestions
Bester JC (December 2016). "Measles and Measles Vaccination: A Review". JAMA Pediatrics. 170 (12): 1209–15. doi:10.1001/jamapediatrics.2016.1787. ISSN 2168-6203. PMID 27695849. /wiki/Doi_(identifier)
Huiming Y, Chaomin W, Meng M (October 2005). Yang H (ed.). "Vitamin A for treating measles in children". The Cochrane Database of Systematic Reviews. 2005 (4): CD001479. doi:10.1002/14651858.CD001479.pub3. PMC 7076287. PMID 16235283. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076287
Rosenbluth T (25 March 2025). "For Some Measles Patients, Vitamin A Remedy Supported by RFK Jr. Leaves Them More Ill". The New York Times. Archived from the original on 25 March 2025. Retrieved 26 March 2025. https://www.nytimes.com/2025/03/25/health/measles-kennedy-vitamin-a.html
Davies DM (28 March 2025). "West Texas children treated for vitamin A toxicity as medical disinformation spreads alongside measles outbreak". TPR. Archived from the original on 19 April 2025. Retrieved 28 March 2025. https://www.tpr.org/public-health/2025-03-27/west-texas-children-treated-for-vitamin-a-toxicity-as-medical-disinformation-spreads-alongside-measles-outbreak
Awotiwon AA, Oduwole O, Sinha A, Okwundu CI (June 2017). "Zinc supplementation for the treatment of measles in children". The Cochrane Database of Systematic Reviews. 2017 (6): CD011177. doi:10.1002/14651858.CD011177.pub3. PMC 6481361. PMID 28631310. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481361
Chen S, Wu T, Kong X, Yuan H (9 November 2011). "Chinese medicinal herbs for measles". The Cochrane Database of Systematic Reviews. 2011 (11): CD005531. doi:10.1002/14651858.CD005531.pub4. ISSN 1469-493X. PMC 7265114. PMID 22071825. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265114
"Management of Obstetric–Gynecologic Patients During a Measles Outbreak". www.acog.org. Retrieved 21 March 2025. https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2024/03/management-of-obstetric-gynecologic-patients-during-a-measles-outbreak
"Measles Complications". U.S. Centers for Disease Control and Prevention (CDC). 25 February 2019. Archived from the original on 19 November 2019. Retrieved 14 May 2019. https://www.cdc.gov/measles/symptoms/complications.html
Di Pietrantonj C, Rivetti A, Marchione P, Debalini MG, Demicheli V (22 November 2021). "Vaccines for measles, mumps, rubella, and varicella in children". The Cochrane Database of Systematic Reviews. 2021 (11): CD004407. doi:10.1002/14651858.CD004407.pub5. ISSN 1469-493X. PMC 8607336. PMID 34806766. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607336
Cohen BE, Durstenfeld A, Roehm PC (July 2014). "Viral causes of hearing loss: a review for hearing health professionals". Trends in Hearing. 18: 2331216514541361. doi:10.1177/2331216514541361. PMC 4222184. PMID 25080364. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222184
Noyce RS, Richardson CD (September 2012). "Nectin 4 is the epithelial cell receptor for measles virus". Trends in Microbiology. 20 (9): 429–39. doi:10.1016/j.tim.2012.05.006. PMID 22721863. /wiki/Doi_(identifier)
Subacute Sclerosing Panencephalitis at NINDS https://www.ninds.nih.gov/health-information/disorders/subacute-sclerosing-panencephalitis
Tesini BL (July 2023). "Measles". Merck Manual Professional. Archived from the original on 8 April 2025. Retrieved 10 April 2025. https://www.merckmanuals.com/professional/pediatrics/common-viral-infections-in-infants-and-children/measles
Centers for Disease Control (CDC) (May 1982). "Recommendation of the Immunization Practices Advisory Committee (ACIP). Measles prevention". MMWR. Morbidity and Mortality Weekly Report. 31 (17): 217–24, 229–31. PMID 6804783. Archived from the original on 23 February 2021. Retrieved 10 May 2019. https://www.cdc.gov/mmwr/preview/mmwrhtml/00001090.htm
Griffin AH (18 May 2019). "Measles and Immune Amnesia". asm.org. American Society for Microbiology. Archived from the original on 18 January 2020. Retrieved 18 January 2020. https://asm.org/Articles/2019/May/Measles-and-Immune-Amnesia
Mina MJ, Kula T, Leng Y, Li M, de Vries RD, Knip M, et al. (1 November 2019). "Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens". Science. 366 (6465): 599–606. Bibcode:2019Sci...366..599M. doi:10.1126/science.aay6485. hdl:10138/307628. ISSN 0036-8075. PMC 8590458. PMID 31672891. https://doi.org/10.1126%2Fscience.aay6485
Guglielmi G (31 October 2019). "Measles erases immune 'memory' for other diseases". Nature. doi:10.1038/d41586-019-03324-7. PMID 33122832. S2CID 208489179. Archived from the original on 2 November 2019. Retrieved 3 November 2019. https://www.nature.com/articles/d41586-019-03324-7
Mina MJ, Metcalf CJ, de Swart RL, Osterhaus AD, Grenfell BT (May 2015). "Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality". Science. 348 (6235): 694–9. Bibcode:2015Sci...348..694M. doi:10.1126/science.aaa3662. PMC 4823017. PMID 25954009. https://doi.org/10.1126%2Fscience.aaa3662
Bakalar N (7 May 2015). "Measles May Increase Susceptibility to Other Infections". The New York Times. Archived from the original on 10 May 2015. Retrieved 7 June 2015. https://archive.nytimes.com/well.blogs.nytimes.com/2015/05/07/measles-may-increase-susceptibility-to-other-infections/
Mina MJ, Kula T, Leng Y, Li M, de Vries RD, Knip M, et al. (1 November 2019). "Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens". Science. 366 (6465): 599–606. Bibcode:2019Sci...366..599M. doi:10.1126/science.aay6485. hdl:10138/307628. ISSN 0036-8075. PMC 8590458. PMID 31672891. https://doi.org/10.1126%2Fscience.aay6485
Bartlett M (1957). "Measles periodicity and community size". J. R. Stat. Soc. Ser. A (120): 48–70.
Black FL (July 1966). "Measles endemicity in insular populations: critical community size and its evolutionary implication". Journal of Theoretical Biology. 11 (2): 207–11. Bibcode:1966JThBi..11..207B. doi:10.1016/0022-5193(66)90161-5. PMID 5965486. /wiki/Bibcode_(identifier)
Ludlow M, McQuaid S, Milner D, de Swart RL, Duprex WP (January 2015). "Pathological consequences of systemic measles virus infection". The Journal of Pathology. 235 (2): 253–65. doi:10.1002/path.4457. PMID 25294240. https://doi.org/10.1002%2Fpath.4457
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. (December 2012). "Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010". Lancet. 380 (9859): 2095–128. doi:10.1016/S0140-6736(12)61728-0. hdl:10536/DRO/DU:30050819. PMC 10790329. PMID 23245604. S2CID 1541253. Archived from the original on 19 May 2020. Retrieved 14 March 2020. https://zenodo.org/record/2557786
Kabra SK, Lodha R (August 2013). "Antibiotics for preventing complications in children with measles". The Cochrane Database of Systematic Reviews. 2013 (8): CD001477. doi:10.1002/14651858.CD001477.pub4. PMC 7055587. PMID 23943263. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055587
"Measles Data and Statistics" (PDF). Archived (PDF) from the original on 10 August 2019. Retrieved 15 August 2019. https://www.cdc.gov/measles/downloads/measlesdataandstatsslideset.pdf
"Measles notifications and deaths in England and Wales: 1940 to 2017". GOV.UK. Archived from the original on 25 July 2019. Retrieved 1 October 2019. https://www.gov.uk/government/publications/measles-deaths-by-age-group-from-1980-to-2013-ons-data/measles-notifications-and-deaths-in-england-and-wales-1940-to-2013
"Complications of measles". U.S. Centers for Disease Control and Prevention (CDC). 3 November 2014. Archived from the original on 3 January 2015. Retrieved 7 November 2014. https://www.cdc.gov/measles/about/complications.html
"Measles Fact Sheet". World Health Organization (WHO). 14 November 2024. Archived from the original on 28 November 2022. Retrieved 10 April 2025. https://www.who.int/en/news-room/fact-sheets/detail/measles
"Chapter 13: Measles". Pink Book Epidemiology and Prevention of Vaccine-Preventable Diseases. U.S. Centers for Disease Control and Prevention (CDC). 24 April 2024. Archived from the original on 19 July 2024. Retrieved 9 April 2025. https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-13-measles.html
Ludlow M, McQuaid S, Milner D, de Swart RL, Duprex WP (January 2015). "Pathological consequences of systemic measles virus infection". The Journal of Pathology. 235 (2): 253–65. doi:10.1002/path.4457. PMID 25294240. https://doi.org/10.1002%2Fpath.4457
Hübschen JM, Gouandjika-Vasilache I, Dina J (12 February 2022). "Measles". Lancet. 399 (10325): 678–690. doi:10.1016/S0140-6736(21)02004-3. ISSN 1474-547X. PMID 35093206. https://pubmed.ncbi.nlm.nih.gov/35093206
"GHO | By category | Measles - Reported cases by WHO region". World Health Organization (WHO). Archived from the original on 25 November 2023. Retrieved 6 October 2023. https://apps.who.int/gho/data/view.main.1520_62?lang=en
"UNICEF Joint Press Release". Archived from the original on 4 February 2015. https://web.archive.org/web/20150204152400/http://www.unicef.org/media/media_38076.html
World Health Organization (December 2009). "Global reductions in measles mortality 2000-2008 and the risk of measles resurgence". Weekly Epidemiological Record. 84 (49): 509–16. hdl:10665/241466. PMID 19960624. /wiki/Hdl_(identifier)
"More than 140,000 die from measles as cases surge worldwide". World Health Organization (WHO) (Press release). 5 December 2019. Archived from the original on 6 August 2020. Retrieved 12 December 2019. https://www.who.int/news-room/detail/05-12-2019-more-than-140-000-die-from-measles-as-cases-surge-worldwide
Brown KE, Rota PA, Goodson JL, Williams D, Abernathy E, Takeda M, et al. (5 July 2019). "Genetic Characterization of Measles and Rubella Viruses Detected Through Global Measles and Rubella Elimination Surveillance, 2016–2018". MMWR. Morbidity and Mortality Weekly Report. 68 (26): 587–591. doi:10.15585/mmwr.mm6826a3. PMC 6613570. PMID 31269012. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613570
Brown KE, Rota PA, Goodson JL, Williams D, Abernathy E, Takeda M, et al. (5 July 2019). "Genetic Characterization of Measles and Rubella Viruses Detected Through Global Measles and Rubella Elimination Surveillance, 2016–2018". MMWR. Morbidity and Mortality Weekly Report. 68 (26): 587–591. doi:10.15585/mmwr.mm6826a3. PMC 6613570. PMID 31269012. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613570
"New measles surveillance data for 2019" (Press release). World Health Organization (WHO). 15 April 2019. Archived from the original on 3 June 2019. Retrieved 4 June 2019. https://www.who.int/immunization/newsroom/measles-data-2019/en/
"More than 140,000 die from measles as cases surge worldwide". World Health Organization (WHO) (Press release). 5 December 2019. Archived from the original on 6 August 2020. Retrieved 12 December 2019. https://www.who.int/news-room/detail/05-12-2019-more-than-140-000-die-from-measles-as-cases-surge-worldwide
Patel MK, Goodson JL, Alexander JP, Kretsinger K, Sodha SV, Steulet C, et al. (13 November 2020). "Progress Toward Regional Measles Elimination — Worldwide, 2000–2019". MMWR. Morbidity and Mortality Weekly Report. 69 (45): 1700–1705. doi:10.15585/mmwr.mm6945a6. ISSN 0149-2195. PMC 7660667. PMID 33180759. Archived from the original on 19 March 2023. Retrieved 7 December 2020. https://www.cdc.gov/mmwr/volumes/69/wr/mm6945a6.htm?s_cid=mm6945a6_w
Patel MK, Goodson JL, Alexander JP, Kretsinger K, Sodha SV, Steulet C, et al. (13 November 2020). "Progress Toward Regional Measles Elimination — Worldwide, 2000–2019". MMWR. Morbidity and Mortality Weekly Report. 69 (45): 1700–1705. doi:10.15585/mmwr.mm6945a6. ISSN 0149-2195. PMC 7660667. PMID 33180759. Archived from the original on 19 March 2023. Retrieved 7 December 2020. https://www.cdc.gov/mmwr/volumes/69/wr/mm6945a6.htm?s_cid=mm6945a6_w
"At least 80 million children under one at risk of diseases such as diphtheria, measles and polio as COVID-19 disrupts routine vaccination efforts, warn Gavi, WHO and UNICEF". World Health Organization (WHO) (Press release). 22 May 2020. Archived from the original on 5 April 2023. Retrieved 25 June 2022. https://www.who.int/news/item/22-05-2020-at-least-80-million-children-under-one-at-risk-of-diseases-such-as-diphtheria-measles-and-polio-as-covid-19-disrupts-routine-vaccination-efforts-warn-gavi-who-and-unicef
"Measles". World Health Organization (WHO). Archived from the original on 30 April 2025. Retrieved 30 April 2025. https://www.who.int/news-room/fact-sheets/detail/measles
"More than half the world faces high measles risk, WHO says". The Straits Times. 21 February 2024. ISSN 0585-3923. Archived from the original on 21 February 2024. Retrieved 21 February 2024. https://www.straitstimes.com/world/more-than-half-the-world-faces-high-measles-risk-who-says
Minta AA (2024). "Progress Toward Measles Elimination — Worldwide, 2000–2023". MMWR. Morbidity and Mortality Weekly Report. 73 (45): 1036–1042. doi:10.15585/mmwr.mm7345a4. ISSN 0149-2195. PMC 11576049. PMID 39541251. https://www.cdc.gov/mmwr/volumes/73/wr/mm7345a4.htm
Christensen J (14 November 2024). "Measles is debilitating and deadly, and cases are surging, WHO and CDC warn". CNN. Retrieved 16 November 2024. https://www.cnn.com/2024/11/14/health/measles-comeback-who-cdc/index.html
Christensen J (14 November 2024). "Measles is debilitating and deadly, and cases are surging, WHO and CDC warn". CNN. Retrieved 16 November 2024. https://www.cnn.com/2024/11/14/health/measles-comeback-who-cdc/index.html
Minta AA (2024). "Progress Toward Measles Elimination — Worldwide, 2000–2023". MMWR. Morbidity and Mortality Weekly Report. 73 (45): 1036–1042. doi:10.15585/mmwr.mm7345a4. ISSN 0149-2195. PMC 11576049. PMID 39541251. https://www.cdc.gov/mmwr/volumes/73/wr/mm7345a4.htm
"50 years of measles vaccination in the UK". Public Health England. Archived from the original on 4 November 2020. Retrieved 15 May 2020. https://web.archive.org/web/20201104095511/https://publichealthengland.exposure.co/50-years-of-measles-vaccination-in-the-uk
Ludlow M, McQuaid S, Milner D, de Swart RL, Duprex WP (January 2015). "Pathological consequences of systemic measles virus infection". The Journal of Pathology. 235 (2): 253–65. doi:10.1002/path.4457. PMID 25294240. https://doi.org/10.1002%2Fpath.4457
Elizabeth Whitman (13 March 2015). "Who Is Stefan Lanka? Court Orders German Measles Denier To Pay 100,000 Euros". International Business Times. Archived from the original on 2 April 2015. Retrieved 31 March 2015. http://www.ibtimes.com/who-stefan-lanka-court-orders-german-measles-denier-pay-100000-euros-1846078
"Europe observes a 4-fold increase in measles cases in 2017 compared to previous year". World Health Organization (WHO) (Press release). 19 February 2018. Archived from the original on 21 February 2018. Retrieved 22 February 2018. http://www.euro.who.int/en/media-centre/sections/press-releases/2018/europe-observes-a-4-fold-increase-in-measles-cases-in-2017-compared-to-previous-year
"WHO EpiData" (PDF). World Health Organization (WHO). February 2019. Archived (PDF) from the original on 29 March 2019. Retrieved 27 March 2019. http://www.euro.who.int/__data/assets/pdf_file/0004/394060/2019_01_Epi_Data_EN_Jan-Dec-2018.pdf?ua=1
"Measles in Europe: record number of both sick and immunized" (Press release). World Health Organization (WHO). 7 February 2019. Archived from the original on 10 February 2019. Retrieved 27 March 2019. http://www.euro.who.int/en/media-centre/sections/press-releases/2019/measles-in-europe-record-number-of-both-sick-and-immunized
"Measles in Europe: record number of both sick and immunized" (Press release). World Health Organization (WHO). 7 February 2019. Archived from the original on 10 February 2019. Retrieved 27 March 2019. http://www.euro.who.int/en/media-centre/sections/press-releases/2019/measles-in-europe-record-number-of-both-sick-and-immunized
"European Region loses ground in effort to eliminate measles". World Health Organization (WHO) (Press release). 29 August 2019. Archived from the original on 14 April 2020. Retrieved 31 August 2019. https://web.archive.org/web/20200414065648/http://www.euro.who.int/en/media-centre/sections/press-releases/2019/european-region-loses-ground-in-effort-to-eliminate-measles
"European Region loses ground in effort to eliminate measles". World Health Organization (WHO) (Press release). 29 August 2019. Archived from the original on 14 April 2020. Retrieved 31 August 2019. https://web.archive.org/web/20200414065648/http://www.euro.who.int/en/media-centre/sections/press-releases/2019/european-region-loses-ground-in-effort-to-eliminate-measles
"European Region reports highest number of measles cases in more than 25 years – UNICEF, WHO/Europe". unicef.org. UNICEF. Archived from the original on 16 March 2025. Retrieved 15 March 2025. https://www.unicef.org/press-releases/european-region-reports-highest-number-measles-cases-more-25-years-unicef-whoeurope
"Region of the Americas is declared free of measles". Pan American Health Organization. 29 September 2016. Archived from the original on 30 September 2016. Retrieved 30 September 2016. https://www.paho.org/hq/index.php?option=com_content&view=article&id=12528:region-americas-declared-free-measles&Itemid=1926&lang=en
"Measles spreads again in the Americas". MercoPress. 28 March 2018. Archived from the original on 4 July 2018. Retrieved 4 July 2018. https://en.mercopress.com/2018/03/28/measles-spreads-again-in-the-americas
"CDC Media Statement: Measles cases in the U.S. are highest since measles was eliminated in 2000". U.S. Centers for Disease Control and Prevention (CDC) (Press release). 26 April 2019. Archived from the original on 15 July 2020. Retrieved 2 May 2019. https://archive.cdc.gov/#/details?url=https://www.cdc.gov/media/releases/2019/s0424-highest-measles-cases-since-elimination.html
"Measles Cases and Outbreaks". U.S. Centers for Disease Control and Prevention (CDC). 6 January 2020. Archived from the original on 1 November 2019. Retrieved 6 January 2020. This article incorporates text from this source, which is in the public domain. https://www.cdc.gov/measles/cases-outbreaks.html
Orenstein WA, Papania MJ, Wharton ME (May 2004). "Measles elimination in the United States". The Journal of Infectious Diseases. 189 (Supplement 1): S1-3. doi:10.1086/377693. PMID 15106120. Figure 1: Reported US measles incidence, 1950–2001. https://doi.org/10.1086%2F377693
"1991: The Philly measles outbreak that killed 9 children". 6abc Philadelphia. 6 February 2015. Archived from the original on 25 November 2020. Retrieved 7 August 2021. https://6abc.com/504818/
"Chapter 13: Measles". Pink Book Epidemiology and Prevention of Vaccine-Preventable Diseases. U.S. Centers for Disease Control and Prevention (CDC). 24 April 2024. Archived from the original on 19 July 2024. Retrieved 9 April 2025. https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-13-measles.html
Papania MJ, Wallace GS, Rota PA, Icenogle JP, Fiebelkorn AP, Armstrong GL, et al. (February 2014). "Elimination of endemic measles, rubella, and congenital rubella syndrome from the Western hemisphere: the US experience". JAMA Pediatrics. 168 (2): 148–55. doi:10.1001/jamapediatrics.2013.4342. PMID 24311021. /wiki/Doi_(identifier)
Papania MJ, Wallace GS, Rota PA, Icenogle JP, Fiebelkorn AP, Armstrong GL, et al. (February 2014). "Elimination of endemic measles, rubella, and congenital rubella syndrome from the Western hemisphere: the US experience". JAMA Pediatrics. 168 (2): 148–55. doi:10.1001/jamapediatrics.2013.4342. PMID 24311021. /wiki/Doi_(identifier)
Centers for Disease Control Prevention (CDC) (February 2008). "Multistate measles outbreak associated with an international youth sporting event--Pennsylvania, Michigan, and Texas, August-September 2007". MMWR. Morbidity and Mortality Weekly Report. 57 (7): 169–73. PMID 18288074. Archived from the original on 18 October 2020. Retrieved 1 February 2018. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5707a1.htm
Gastañaduy PA, Budd J, Fisher N, Redd SB, Fletcher J, Miller J, et al. (October 2016). "A Measles Outbreak in an Underimmunized Amish Community in Ohio". The New England Journal of Medicine. 375 (14): 1343–1354. doi:10.1056/NEJMoa1602295. PMID 27705270. https://doi.org/10.1056%2FNEJMoa1602295
Gastañaduy PA, Budd J, Fisher N, Redd SB, Fletcher J, Miller J, et al. (October 2016). "A Measles Outbreak in an Underimmunized Amish Community in Ohio". The New England Journal of Medicine. 375 (14): 1343–1354. doi:10.1056/NEJMoa1602295. PMID 27705270. https://doi.org/10.1056%2FNEJMoa1602295
Gastañaduy PA, Budd J, Fisher N, Redd SB, Fletcher J, Miller J, et al. (October 2016). "A Measles Outbreak in an Underimmunized Amish Community in Ohio". The New England Journal of Medicine. 375 (14): 1343–1354. doi:10.1056/NEJMoa1602295. PMID 27705270. https://doi.org/10.1056%2FNEJMoa1602295
"Year in Review: Measles Linked to Disneyland". 2 December 2015. Archived from the original on 19 May 2017. Retrieved 26 May 2017. https://blogs.cdc.gov/publichealthmatters/2015/12/year-in-review-measles-linked-to-disneyland/
Clemmons NS, Gastanaduy PA, Fiebelkorn AP, Redd SB, Wallace GS (April 2015). "Measles - United States, January 4-April 2, 2015" (PDF). MMWR. Morbidity and Mortality Weekly Report. 64 (14): 373–6. PMC 5779542. PMID 25879894. Archived (PDF) from the original on 13 July 2020. Retrieved 1 November 2019. https://www.cdc.gov/mmwr/pdf/wk/mm6414.pdf
"Measles Outbreak — California, December 2014–February 2015". U.S. Centers for Disease Control and Prevention (CDC). Archived from the original on 10 December 2020. Retrieved 8 January 2022. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6406a5.htm
"Measles kills first patient in 12 years". USA Today. 2 July 2015. Archived from the original on 2 July 2015. Retrieved 2 July 2015. https://www.usatoday.com/story/news/2015/07/02/measles-death-washington-state/29624385/
"First Measles Death in US Since 2003 Highlights the Unknown Vulnerables – Phenomena: Germination". National Geographic Society. 2 July 2015. Archived from the original on 31 May 2020. Retrieved 13 May 2020. https://web.archive.org/web/20200531020834/https://www.nationalgeographic.com/science/phenomena/2015/07/02/measles-death-us/
"First Measles Death In 12 Years Renews Vaccination Concerns". NPR. 6 July 2015. Archived from the original on 24 December 2019. Retrieved 23 April 2019. https://web.archive.org/web/20191224204938/https://www.npr.org/2015/07/06/420594973/first-measles-death-in-12-years-renews-vaccination-concerns
"Maine confirms its first case of measles in 20 years". CBS News. 27 June 2017. Archived from the original on 28 June 2017. Retrieved 28 June 2017. https://www.cbsnews.com/news/maine-confirms-first-case-measles-20-years/
"Measles case confirmed in Portland, about 500 people possibly exposed". KATU. Archived from the original on 7 August 2020. Retrieved 3 July 2018. http://katu.com/news/local/measles-case-confirmed-in-portland-about-500-people-exposed
"TABLE 1. Weekly cases* of selected infrequently reported notifiable diseases (". wonder.cdc.gov. Archived from the original on 22 October 2020. Retrieved 12 January 2019. https://wonder.cdc.gov/nndss/static/2018/52/2018-52-table1.html
Alltucker K (11 February 2019). "A quarter of all kindergartners in Washington county aren't immunized. Now there's a measles crisis". USA Today. Archived from the original on 11 February 2019. Retrieved 11 February 2019. https://www.usatoday.com/story/news/health/2019/02/11/measles-spread-anti-vaccination-communities-new-york-clar-county-washington/2812667002/
Howard J (9 January 2019). "New York tackles 'largest measles outbreak' in state's recent history as cases spike globally". CNN. Archived from the original on 11 January 2019. Retrieved 12 January 2019. https://www.cnn.com/2019/01/08/health/measles-outbreak-ny-bn/index.html
"Washington state is averaging more than one measles case per day in 2019". NBC News. 4 February 2019. Archived from the original on 5 February 2019. Retrieved 5 February 2019. https://www.nbcnews.com/storyline/measles-outbreak/measles-outbreak-southwestern-washington-rises-50-cases-n966751
"Amid Measles Outbreak, Anti-Vaxx Parents Have Put Others' Babies At Risk". MSN. Archived from the original on 30 March 2019. Retrieved 5 February 2019. https://web.archive.org/web/20190330170245/https://www.msn.com/en-ph/lifestyle/family/amid-measles-outbreak-anti-vaxx-parents-have-put-others-e2-80-99-babies-at-risk/ar-BBTbIBq
Belluz J (27 January 2019). "Washington declared a public health emergency over measles. Thank vaccine-refusing parents". Vox. Archived from the original on 5 February 2019. Retrieved 5 February 2019. https://www.vox.com/2019/1/27/18199514/measles-outbreak-2018-clark-county-washington
Gander K (28 January 2019). ""Dangerous" anti-vaxx warning issued by Washington officials as cases in measles outbreak continue to rise". Newsweek. Archived from the original on 4 February 2019. Retrieved 5 February 2019. https://www.newsweek.com/dangerous-anti-vaxx-warning-issued-washington-officials-cases-measles-1306997
Howard J, Goldschmidt D (24 April 2019). "US measles outbreak is largest since disease was declared eliminated in 2000". CNN. Archived from the original on 24 April 2019. Retrieved 24 April 2019. https://www.cnn.com/2019/04/24/health/measles-outbreak-record-us-bn/index.html
Alltucker K (11 February 2019). "A quarter of all kindergartners in Washington county aren't immunized. Now there's a measles crisis". USA Today. Archived from the original on 11 February 2019. Retrieved 11 February 2019. https://www.usatoday.com/story/news/health/2019/02/11/measles-spread-anti-vaccination-communities-new-york-clar-county-washington/2812667002/
Goldstein-Street J (28 January 2019). "Amid measles outbreak, legislation proposed to ban vaccine exemptions". The Seattle Times. Archived from the original on 29 January 2019. Retrieved 28 January 2019. https://www.seattletimes.com/seattle-news/amid-measles-outbreak-legislation-proposed-to-ban-vaccine-exemptions/
Tanne JH (April 2019). "New York City mayor declares measles public health emergency". BMJ. 365: l1724. doi:10.1136/bmj.l1724. PMID 30971409. S2CID 145979493. /wiki/Doi_(identifier)
Howard J, Goldschmidt D (24 April 2019). "US measles outbreak is largest since disease was declared eliminated in 2000". CNN. Archived from the original on 24 April 2019. Retrieved 24 April 2019. https://www.cnn.com/2019/04/24/health/measles-outbreak-record-us-bn/index.html
"CDC Media Statement: Measles cases in the U.S. are highest since measles was eliminated in 2000". U.S. Centers for Disease Control and Prevention (CDC) (Press release). 26 April 2019. Archived from the original on 15 July 2020. Retrieved 2 May 2019. https://archive.cdc.gov/#/details?url=https://www.cdc.gov/media/releases/2019/s0424-highest-measles-cases-since-elimination.html
"CDC Media Statement: Measles cases in the U.S. are highest since measles was eliminated in 2000". U.S. Centers for Disease Control and Prevention (CDC) (Press release). 26 April 2019. Archived from the original on 15 July 2020. Retrieved 2 May 2019. https://archive.cdc.gov/#/details?url=https://www.cdc.gov/media/releases/2019/s0424-highest-measles-cases-since-elimination.html
"Measles Cases and Outbreaks". U.S. Centers for Disease Control and Prevention (CDC). 6 January 2020. Archived from the original on 1 November 2019. Retrieved 6 January 2020. This article incorporates text from this source, which is in the public domain. https://www.cdc.gov/measles/cases-outbreaks.html
"Measles Cases and Outbreaks". U.S. Centers for Disease Control and Prevention (CDC). 6 January 2020. Archived from the original on 1 November 2019. Retrieved 6 January 2020. This article incorporates text from this source, which is in the public domain. https://www.cdc.gov/measles/cases-outbreaks.html
"Measles Cases and Outbreaks". U.S. Centers for Disease Control and Prevention (CDC). 6 January 2020. Archived from the original on 1 November 2019. Retrieved 6 January 2020. This article incorporates text from this source, which is in the public domain. https://www.cdc.gov/measles/cases-outbreaks.html
"Measles Cases and Outbreaks". U.S. Centers for Disease Control and Prevention (CDC). 29 September 2023. Archived from the original on 15 May 2024. Retrieved 6 October 2023. https://www.cdc.gov/measles/data-research/
Mukherjee N (26 February 2025). "Child in West Texas is first US measles death in a decade". CNN. Retrieved 26 February 2025. https://www.cnn.com/2025/02/26/health/texas-measles-death/index.html
IANS (29 March 2025). "Measles outbreak 2025: US cases surge past 2024 total". Gulf News. Retrieved 30 March 2025. https://gulfnews.com/world/americas/measles-outbreak-2025-us-cases-surge-past-2024-total-1.500076568
Lenharo M (26 July 2016). "Sarampo está eliminado do Brasil, segundo comitê internacional" (in Portuguese). G1. Archived from the original on 27 July 2016. Retrieved 26 July 2016. http://g1.globo.com/bemestar/noticia/2016/07/sarampo-esta-eliminado-do-brasil-segundo-comite-internacional.html
"Sarampo está eliminado do Brasil, segundo comitê internacional". Bem Estar (in Brazilian Portuguese). 26 July 2016. Archived from the original on 27 July 2016. Retrieved 19 December 2018. http://g1.globo.com/bemestar/noticia/2016/07/sarampo-esta-eliminado-do-brasil-segundo-comite-internacional.html
"Brasil já tem mais de mil casos de sarampo em 2018, segundo Ministério da Saúde". G1 (in Brazilian Portuguese). 2 August 2018. Archived from the original on 9 November 2020. Retrieved 19 December 2018. https://g1.globo.com/bemestar/noticia/2018/08/02/brasil-ja-tem-mais-de-mil-casos-de-sarampo-em-2018-segundo-ministerio-da-saude.ghtml
Saúde Md. "Ministério da Saúde atualiza casos de sarampo". portalms.saude.gov.br (in Brazilian Portuguese). Archived from the original on 20 April 2019. Retrieved 2 August 2018. http://portalms.saude.gov.br/noticias/agencia-saude/43946-ministerio-da-saude-atualiza-casos-de-sarampo-2
"Brasil já tem mais de mil casos de sarampo em 2018, segundo Ministério da Saúde". G1 (in Brazilian Portuguese). 2 August 2018. Archived from the original on 9 November 2020. Retrieved 19 December 2018. https://g1.globo.com/bemestar/noticia/2018/08/02/brasil-ja-tem-mais-de-mil-casos-de-sarampo-em-2018-segundo-ministerio-da-saude.ghtml
Saúde Md. "Ministério da Saúde atualiza casos de sarampo". portalms.saude.gov.br (in Brazilian Portuguese). Archived from the original on 20 April 2019. Retrieved 2 August 2018. http://portalms.saude.gov.br/noticias/agencia-saude/43946-ministerio-da-saude-atualiza-casos-de-sarampo-2
Lien Chau (18 April 2014). "Vietnam minister calls for calm in face of 8,500 measles cases, 114 fatalities". Thanh Niên. Archived from the original on 18 April 2014. Retrieved 19 April 2014. https://web.archive.org/web/20140418220953/http://www.thanhniennews.com/health/vietnam-minister-calls-for-calm-in-face-of-8500-measles-cases-114-fatalities-25423.html
Quốc Thanh (30 May 2014). "Bộ Y tế: "VN đã phản ứng rất nhanh đối với dịch sởi"" [Ministry of Health: "Vietnam has responded very quickly to measles"] (in Vietnamese). Tuổi Trẻ. Archived from the original on 31 May 2014. Retrieved 19 April 2014. http://tuoitre.vn/Chinh-tri-Xa-hoi/610133/bo-y-te--vn-da-phan-ung-rat-nhanh-doi-voi-dich-soi.html
"WHO doctors in Myanmar's Naga areas identify 'mystery disease'". Eastern Mirror Nagaland. 6 August 2016. Archived from the original on 19 August 2017. Retrieved 8 August 2016. https://www.easternmirrornagaland.com/who-doctors-in-myanmars-naga-areas-identify-mystery-disease/
"Myanmar (02): (SA) fatal, measles confirmed". www.promedmail.org (Archive Number: 20160806.4398118). International Society for Infectious Diseases. Archived from the original on 20 August 2016. Retrieved 8 August 2016. https://web.archive.org/web/20160820090754/http://www.promedmail.org/post/4398118
"Philippines measles update: Nearly 600 cases in 2 days". Outbreak News Today. 26 March 2019. Archived from the original on 30 August 2019. Retrieved 30 August 2019. http://outbreaknewstoday.com/philippines-measles-update-nearly-600-cases-2-days-76902/
Oon AJ (17 June 2019). "A Measles Outbreak Is The Cause of 15 Orang Asli Deaths In Kelantan". Says.com. Archived from the original on 27 August 2019. Retrieved 30 August 2019. https://says.com/my/news/mysterious-illness-causing-deaths-of-kampung-kuala-koh-orang-asli-identified-as-measles
Tay R (18 June 2019). "The mysterious illness that caused 15 deaths in a Malaysian tribe has been linked to a measles outbreak". Business Insider Malaysia. Archived from the original on 30 August 2019. Retrieved 30 August 2019. https://www.businessinsider.my/the-mysterious-illness-that-caused-15-deaths-in-a-malaysian-tribe-has-been-linked-to-a-measles-outbreak/
Unson J (24 March 2024). "Measles outbreak declared in BARMM". The Philippine Star. Retrieved 24 March 2024. https://qa.philstar.com/nation/2024/03/24/2342863/measles-outbreak-declared-barmm
Government of Samoa (22 December 2019). "National Emergency Operation Centre, update on the measles outbreak: (press release 36) 22 December, 2019". @samoagovt. Archived from the original on 16 March 2020. Retrieved 22 December 2019. https://www.facebook.com/samoagovt/posts/2835748539789483
"New measles surveillance data from WHO". World Health Organization (WHO). Archived from the original on 12 August 2019. Retrieved 23 November 2019. https://web.archive.org/web/20190812222426/https://www.who.int/immunization/newsroom/new-measles-data-august-2019/en/
Bezain L (14 April 2019). "Measles outbreak kills more than 1200 in Madagascar". Associated Press. Retrieved 13 May 2019. https://www.apnews.com/0cd4deb8141742b5903fbef3cb0e8afa
"Nearly 5,000 dead in world's worst measles outbreak". 21 November 2019. Archived from the original on 11 February 2020. Retrieved 23 November 2019. https://web.archive.org/web/20200211233419/https://www.bbc.com/news/world-africa-50506743
Ratcliffe R (22 November 2019). "Children bear the brunt as the world's biggest measles epidemic sweeps Congo". The Guardian. ISSN 0261-3077. Archived from the original on 7 May 2020. Retrieved 23 November 2019. https://web.archive.org/web/20200507233821/https://www.theguardian.com/global-development/2019/nov/22/children-bear-the-brunt-as-the-worlds-biggest-measles-epidemic-sweeps-congo
"Measles and Rubella Surveillance Data". World Health Organization (WHO). Archived from the original on 3 May 2020. Retrieved 23 November 2019. https://web.archive.org/web/20200503130400/https://www.who.int/immunization/monitoring_surveillance/burden/vpd/surveillance_type/active/measles_monthlydata/en/
Furuse Y, Suzuki A, Oshitani H (March 2010). "Origin of measles virus: divergence from rinderpest virus between the 11th and 12th centuries". Virology Journal. 7: 52. doi:10.1186/1743-422X-7-52. PMC 2838858. PMID 20202190. https://doi.org/10.1186%2F1743-422X-7-52
Düx A, Lequime S, Patrono LV, Vrancken B, Boral S, Gogarten JF, et al. (30 December 2019). "The history of measles: from a 1912 genome to an antique origin". bioRxiv: 2019.12.29.889667. doi:10.1101/2019.12.29.889667. https://doi.org/10.1101%2F2019.12.29.889667
Kupferschmidt K (30 December 2019). "Measles may have emerged when large cities rose, 1500 years earlier than thought". Science. doi:10.1126/science.aba7352. S2CID 214470603. /wiki/Doi_(identifier)
Furuse Y, Suzuki A, Oshitani H (March 2010). "Origin of measles virus: divergence from rinderpest virus between the 11th and 12th centuries". Virology Journal. 7: 52. doi:10.1186/1743-422X-7-52. PMC 2838858. PMID 20202190. https://doi.org/10.1186%2F1743-422X-7-52
H. Haeser's conclusion, in Lehrbuch der Geschichte der Medicin und der epidemischen Krankenheiten III:24–33 (1882), followed by Zinsser in 1935.
"Chapter 13: Measles". Pink Book Epidemiology and Prevention of Vaccine-Preventable Diseases. U.S. Centers for Disease Control and Prevention (CDC). 24 April 2024. Archived from the original on 19 July 2024. Retrieved 9 April 2025. https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-13-measles.html
Cohen SG (February 2008). "Measles and immunomodulation". The Journal of Allergy and Clinical Immunology. 121 (2): 543–4. doi:10.1016/j.jaci.2007.12.1152. PMID 18269930. Archived from the original on 4 December 2020. Retrieved 6 September 2019. https://zenodo.org/record/1259085
Furuse Y, Suzuki A, Oshitani H (March 2010). "Origin of measles virus: divergence from rinderpest virus between the 11th and 12th centuries". Virology Journal. 7: 52. doi:10.1186/1743-422X-7-52. PMC 2838858. PMID 20202190. https://doi.org/10.1186%2F1743-422X-7-52
Black FL (July 1966). "Measles endemicity in insular populations: critical community size and its evolutionary implication". Journal of Theoretical Biology. 11 (2): 207–11. Bibcode:1966JThBi..11..207B. doi:10.1016/0022-5193(66)90161-5. PMID 5965486. /wiki/Bibcode_(identifier)
Byrne JP (2008). Encyclopedia of Pestilence, Pandemics, and Plagues: A–M. ABC-CLIO. p. 413. ISBN 978-0-313-34102-1. Archived from the original on 13 November 2013. 978-0-313-34102-1
Harper K (11 March 2020). "What Makes Viruses Like COVID-19 Such a Risk for Human Beings? The Answer Goes Back Thousands of Years". Time. Archived from the original on 7 March 2023. Retrieved 18 November 2020. https://time.com/5800558/coronavirus-human-civilization/
Harper K (11 March 2020). "What Makes Viruses Like COVID-19 Such a Risk for Human Beings? The Answer Goes Back Thousands of Years". Time. Archived from the original on 7 March 2023. Retrieved 18 November 2020. https://time.com/5800558/coronavirus-human-civilization/
Harper K (11 March 2020). "What Makes Viruses Like COVID-19 Such a Risk for Human Beings? The Answer Goes Back Thousands of Years". Time. Archived from the original on 7 March 2023. Retrieved 18 November 2020. https://time.com/5800558/coronavirus-human-civilization/
Harper K (11 March 2020). "What Makes Viruses Like COVID-19 Such a Risk for Human Beings? The Answer Goes Back Thousands of Years". Time. Archived from the original on 7 March 2023. Retrieved 18 November 2020. https://time.com/5800558/coronavirus-human-civilization/
"Chapter 13: Measles". Pink Book Epidemiology and Prevention of Vaccine-Preventable Diseases. U.S. Centers for Disease Control and Prevention (CDC). 24 April 2024. Archived from the original on 19 July 2024. Retrieved 9 April 2025. https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-13-measles.html
Migration and Disease. Digital History. https://web.archive.org/web/20090101183418/http://www.digitalhistory.uh.edu/database/article_display.cfm?HHID=422
"Our History". Fiji National University. Archived from the original on 10 April 2015. https://web.archive.org/web/20150410002823/http://www.fsm.ac.fj/index.php?option=com_content&view=article&id=114&Itemid=148
Bhaumik S (16 May 2006). "Measles hits rare Andaman tribe". BBC News Online. Archived from the original on 23 August 2011. http://news.bbc.co.uk/2/hi/south_asia/4987406.stm
Crum FS (April 1914). "A Statistical Study of Measles". American Journal of Public Health. IV (4): 289–309. doi:10.2105/AJPH.4.4.289-a. PMC 1286334. PMID 18009016. https://doi.org/10.2105%2FAJPH.4.4.289-a
Rota PA, Moss WJ, Takeda M, de Swart RL, Thompson KM, Goodson JL (July 2016). "Measles". Nature Reviews. Disease Primers. 2: 16049. doi:10.1038/nrdp.2016.49. PMID 27411684. https://doi.org/10.1038%2Fnrdp.2016.49
"Chapter 13: Measles". Pink Book Epidemiology and Prevention of Vaccine-Preventable Diseases. U.S. Centers for Disease Control and Prevention (CDC). 24 April 2024. Archived from the original on 19 July 2024. Retrieved 9 April 2025. https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-13-measles.html
Baker JP (1 September 2011). "The First Measles Vaccine". Pediatrics. 128 (3): 435–437. doi:10.1542/peds.2011-1430. ISSN 0031-4005. PMID 21873696. Archived from the original on 18 August 2022. Retrieved 21 April 2025. https://publications.aap.org/pediatrics/article-abstract/128/3/435/30684/The-First-Measles-Vaccine?redirectedFrom=fulltext
"Chapter 13: Measles". Pink Book Epidemiology and Prevention of Vaccine-Preventable Diseases. U.S. Centers for Disease Control and Prevention (CDC). 24 April 2024. Archived from the original on 19 July 2024. Retrieved 9 April 2025. https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-13-measles.html
Centers for Disease Control (CDC) (December 1989). "Measles prevention". MMWR Supplements. 38 (9): 1–18. PMID 2513473. Archived from the original on 15 May 2012. Retrieved 10 September 2017. https://www.cdc.gov/mmwr/preview/mmwrhtml/00041753.htm
Offit PA (2007). Vaccinated: One Man's Quest to Defeat the World's Deadliest Diseases. Washington, D.C.: Smithsonian. ISBN 978-0-06-122796-7. 978-0-06-122796-7
"Measles: Questions and Answers" (PDF). Immunization Action Coalition. Archived from the original on 24 January 2013. https://web.archive.org/web/20130124052237/http://www.immunize.org/catg.d/p4209.pdf
"Chapter 13: Measles". Pink Book Epidemiology and Prevention of Vaccine-Preventable Diseases. U.S. Centers for Disease Control and Prevention (CDC). 24 April 2024. Archived from the original on 19 July 2024. Retrieved 9 April 2025. https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-13-measles.html
Lanka S [in German] (April 1995). "HIV; Reality or artefact?". Virusmyth.com. Archived from the original on 26 March 2015. Retrieved 31 March 2015. https://de.wikipedia.org/wiki/Stefan_Lanka
"Das Masern-Virus 100.000 € Belohnung! WANTeD Der Durchmesser" (PDF) (in German). 24 November 2011. Archived from the original (PDF) on 2 April 2015. Retrieved 31 March 2015. https://web.archive.org/web/20150402163126/http://magonia.com/files/stefan-lanka-sarampion.pdf
Elizabeth Whitman (13 March 2015). "Who Is Stefan Lanka? Court Orders German Measles Denier To Pay 100,000 Euros". International Business Times. Archived from the original on 2 April 2015. Retrieved 31 March 2015. http://www.ibtimes.com/who-stefan-lanka-court-orders-german-measles-denier-pay-100000-euros-1846078
"Germany court orders measles sceptic to pay 100,000 euros". BBC News Online. 12 March 2015. Archived from the original on 31 March 2015. Retrieved 31 March 2015. https://www.bbc.com/news/world-europe-31864218
"Disappointing outcome of Bardens vs. Lanka: measles proven to exist, but anti-vaxxer Lanka keeps his money". 23 January 2017. Archived from the original on 1 July 2017. https://web.archive.org/web/20170701211525/http://www.pepijnvanerp.nl/2017/01/disappointing-outcome-of-bardens-vs-lanka-measles-proven-to-exist-but-anti-vaxxer-lanka-keeps-his-money/
Novella S (13 March 2015). "Yes, Dr. Lanka, Measles is Real". NeuroLogica Blog. Archived from the original on 31 March 2015. Retrieved 31 March 2015. /wiki/Steven_Novella
Abramson BD (2025). "Ch. 15-Specific Vaccines". Vaccine, Vaccination, and Immunization Law, Third Edition. Bloomberg Law. p. 29. ISBN 979-8-34170-407-7. 979-8-34170-407-7
"Measles Cases and Outbreaks". U.S. Centers for Disease Control and Prevention (CDC). 6 January 2020. Archived from the original on 1 November 2019. Retrieved 6 January 2020. This article incorporates text from this source, which is in the public domain. https://www.cdc.gov/measles/cases-outbreaks.html
Scirè G (1 January 2021). "Modelling and assessing public health policies to counteract Italian measles outbreaks". International Journal of Simulation and Process Modelling. 16 (4): 271–284. doi:10.1504/IJSPM.2021.118832. hdl:10447/513505. ISSN 1740-2123. Archived from the original on 20 November 2022. Retrieved 6 May 2022. https://www.inderscienceonline.com/doi/abs/10.1504/IJSPM.2021.118832
"Measles Cases and Outbreaks". U.S. Centers for Disease Control and Prevention (CDC). 6 January 2020. Archived from the original on 1 November 2019. Retrieved 6 January 2020. This article incorporates text from this source, which is in the public domain. https://www.cdc.gov/measles/cases-outbreaks.html